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Abstract 
 
This study investigated the effects of a range of zinc oxide (ZnO) and titanium 
dioxide (TiO2) particulates, including those used in nanosunscreens, on the HaCaT 
human keratinocyte cell line in the presence and absence of UVA and UVB radiation 
(UVAB radiation). The HaCaT cells were chosen as a model human skin cell line for 
the in vitro exposure system, and the parameters investigated included cytotoxicity, 
intracellular Zn2+ and reactive oxygen species (ROS), interleukin-6 (IL-6) cytokine 
release, and if the mode of cell death was via the apoptotic or necrotic pathway. 
Cytotoxicity of the particulates to HaCaT cells was determined using the MTS 
viability assay. ZnO particulates and ZnCl2 were found to be cytotoxic to HaCaT 
cells, with significant levels of cytotoxicity occurring within 8-12 h of exposure at 
concentrations ≥ 30 µg/mL. Conversely, TiO2 particulates were found to be well-
tolerated by HaCaT cells, even at extremely high doses (5 mg/mL). The effect of 
UVAB radiation was found to cause a ~50% decrease in cell viability at 24 h post 
exposure, compared to non-irradiated controls. The presence of particulate exposure 
with UVAB radiation further contributed to the cytotoxicity induced by UV alone.  
The proposed paradigm of ZnO particulate cytotoxicity was investigated in this 
study. The theory suggests that Zn2+ from the dissolution of the particulates 
themselves are responsible for the cytotoxicity in HaCaT cells. The level of 
intracellular Zn2+ was determined via flow cytometry using the specific fluorophore, 
zinquin ethyl ester. In this study, the amount of intracellular Zn2+ generated from 
particulate exposure increased in a dose-dependent manner. Furthermore, this was 
found to correlate with the decrease in cell viability observed using the MTS assay. 
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Intracellular ROS production was measured via flow cytometric detection of 
peroxides and mitochondrial superoxide using DCF-DA and MitoSOX, respectively. 
Particulate exposure was found to increase mitochondrial superoxide production in a 
dose-dependent manner, but had no overall effect on peroxide generation. 
Furthermore, mitochondrial superoxide production was found to correlate with a 
decrease in cell viability, however peroxide production did not. 
Keratinocytes can release cytokines when damaged and the production of IL-6 was 
measured in this study via ELISA. The ability of particulates to stimulate IL-6 
release was found to be negligible. In fact, IL-6 was found to be stimulated only by 
UVAB radiation, which was not altered by co-exposure to particulates. 
Cell death by apoptosis and necrosis was assessed via flow cytometry using Annexin 
V-FITC and propidium iodide. The mode of cell death induced by ZnO particulates 
in HaCaT cells was found to be predominantly necrosis at all concentrations tested. 
However, as this was measured after 24 h of exposure to particulates, it may be 
possible that early apoptotic events may not have been detected.  
In conclusion, this study used a variety of techniques in determining the direct effects 
of ZnO and TiO2 particulates on HaCaT cells, and their interactions with co-exposure 
to UVAB radiation. Importantly, the concentrations of NPs used in this in vitro study 
are at least two orders of magnitude higher than would be expected from using a 
nanosunscreen. This indicates that the particulates used in sunscreens are highly 
likely to be safe to use by consumers when applied on the skin. However, as this 
study was performed in immortalised human skin cells, more complex cell models, 
such as primary cell cultures and human skin explants, would also need to be 
investigated in order to provide further confirmation of these results. 
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1.1 General Introduction 
The nanotechnology (NT) industry is generating interest across the world, not only 
for the potential advances it may allow for modern applications, but for the possible 
hazards it may pose to public health [1]. Particular interest has come from the use of 
metal oxides, such as ZnO and TiO2, which are incorporated into sunscreens for their 
ultraviolet (UV) filtering properties. In their nano-form, they are formulated to be 
more aesthetically pleasing whilst still retaining their broad-spectrum 
photoprotective abilities. Whilst these properties are beneficial to users and 
manufacturers of skin care products, their effects on the skin are not well understood.  
 
1.2 Nanotechnology 
NT is at the forefront of modern applications and has the potential for producing 
exciting and unique products. The term is extremely broad as it spans various 
industries that include scientific research and its sub-disciplines, such as engineering 
and electronics [2]. It was first defined as the “processing of, separation, 
consolidation and deformation of materials by one atom or by one molecule” [3]. 
This however has evolved into the current definition of the manipulation of materials 
at the nanometre level (between 1-100 nm) [4]. Whilst NT was not defined until 
1974, the actual idea behind its principles is credited to American Nobel Prize 
laureate Richard Feynman, who in 1959 delivered a lecture to the American Physical 
Society entitled, “There’s plenty of room at the bottom” [5]. In this lecture he 
proposed the idea of manipulating matter at an atomic level to generate a desired 
effect [6]. It took almost 30 years before his concept was realised, with the discovery 
of the carbon fullerene and the development of the atomic force microscope by IBM, 
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which finally gave researchers the ability to image and measure materials at an 
atomic level.  
 
1.2.1 Nanotechnology Trade 
Current spending in the NT field is increasing exponentially (Figure 1.1) as well as 
the amount of literature being produced, compared to a decade ago (Figure 1.2).  The 
United States government alone had contributed $8 billion for research and 
development of NT strategies up to 2004. It is estimated that by 2015, this spending 
will reach approximately $2.84 trillion [7]. In 2009, Australia’s contribution to the 
NT industry was only $108 million [7]. Whilst at the time this amount was somewhat 
dwarfed compared to other leading countries in the field, the Australian government 
has supplied significant new funding in this area resulting in the establishment of ~80 
companies and the development of specialised courses in most of its universities [1]. 
The emerging research into the use of NT emanates around the design, synthesis, 
characterisation and use of nanoparticles (NPs).  
 
 
 
 
 
 
 
Figure 1.1. Public spending on nanotechnology [8]. 
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Figure 1.2. Increased nanotechnology based publications from 1990-2008 [9].  
 
1.3 Nanoparticles 
The current ISO definition of a NP states that all dimensions of the object must be 
less than 100 nm [4]. They differ from the bulk material in relation to various 
properties, such as electrical, magnetic, structural, morphological, chemical and 
physical properties [10, 11]. These properties change with decreasing size of the NP. 
This is because, with decreasing particle size the proportion (or percent) of surface 
molecules on the NPs become greater [12], as seen in Figure 1.3. 
The ability to manipulate and exploit NPs for their differing properties has allowed 
for the production of various products. One interesting product is self-cleaning glass; 
according to the manufacturer “Pilkington Activ”,  NPs that are used in ‘self-
cleaning glass when exposed to UV radiation, cause the NPs to become energized 
and breakdown dirt on the glass, which can then be cleared by water due to the 
hydrophilicity of glass [13]. Silver NPs in antimicrobial bandages are used to block 
cellular respiration of microbes [13]. Nano-enhanced barriers and contaminant 
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sensors aid in preventing/detecting the presence of E.coli [14]. They may also be 
incorporated into clothing and sunscreen for their UV protective effects [13]. These 
are some examples of the many thousands of applications in which NPs are currently 
being utilized. Whilst the potential uses in the NT industry are generating interest, 
there is a corresponding interest in the safety of using these NPs. In order to combat 
public doubt in this technology, experts have suggested the need to create greater 
awareness and develop guidelines entailing the safe use of NPs in the NT industry [7, 
15]. Safe Work Australia has also outlined the difficulty in monitoring NPs as they 
can form unpredictable structures in different solutions, which may in turn alter their 
toxicological profiles [16]. Consequently, it has been suggested that there is a need 
for the regulation of NPs. 
 
 
Figure 1.3. Effect of particle size vs percent surface molecules. Larger sized particles 
have a very low percentage of surface molecules, however as the size of the particles 
become smaller, the percentage of surface molecules increases exponentially [12].  
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1.3.1 Nanoparticle Regulation 
The regulation and control of NPs has become an important issue. In 2004, The 
Royal Academy of Sciences published a report which included important regulatory 
issues that governments would need to address [17]. In short, they outlined the need 
for regulating and identifying the hazards of the particular materials and the 
probability of exposure, which in turn determines the risk of that particular material. 
They stated that “whereby a situation arises such that a particular material be 
controlled, options exist such as: labelling of ingredients, waste disposal restrictions 
and prohibition etc.” [17].  
In 2010 Seaton et al. [18] described the bleak scenario in the UK that, whilst the 
regulatory framework was set up to deal with nano-related issues, there was nothing 
currently in place that would compel someone to notify the relevant bodies if a bulk 
sized material is replaced by a nano-sized one of the same material – unfortunately 
this is still the case today. 
In light of all this, recommendations by the Commission of the European 
Communities for those involved in NT research states that all activities should take 
place via the ‘precautionary principle’ [19]. It is important to note that whilst these 
recommendations were published in their report as a ‘code of conduct’, none of it has 
been legislated by the relevant governments.   
 
1.3.2 Nanoparticle Characterisation 
Another parameter that is lagging in NP research is the need for a specific set of 
characterisation endpoints. It is widely accepted that the properties of materials at the 
nano and macro levels differ thus, when investigating the toxicological effects of 
11 
 
NPs on humans and the environment, there is a need for a set range of 
characterisation techniques to be performed [9, 20, 21]. This is to ensure that 
accurate and reproducible nanotoxicity testing can occur. Warheit et al. [22] 
described that a lack of characterisation would mean that NT research would be 
devalued due to there being an unknown amount of variability within experiments, 
and also that current conflicting data may be better explained if there were a set 
number of characterisation techniques that researchers had to adhere to. Cong et al. 
[23] published a report stating that a common problem in the reporting of various 
characterisation endpoints such as size, shape and surface area are the fact that they 
are often done so based on the initial powder or dispersion liquid and not the 
endpoint volume that they will be tested in. The problem with this is that NPs often 
behave and undergo changes in their physicochemical properties when they are 
moved from one biological system to another (i.e. water to cell culture media) [23]. 
Another unfortunate factor is that what may be included within the manufacturer’s 
information, may in fact be different to what an individual may find from their own 
testing. The possible reasoning for all of this may be due to batch to batch variability 
and changes in manufacturer’s protocols for synthesising the materials. This further 
emphasizes the need to have an accurate and standardised set of characterisation 
principles that all users of nanomaterials must follow.  
In 2010, the Royal Society of Chemistry, published a list of the more common 
characterisation techniques that are used by NT researchers [24]. These are separated 
into solid phase (powders) and liquid phase (dispersed in liquid), respectively. They 
included size determination via electron microscopy and dynamic light scattering, 
surface area via Brunauer, Emmet and Teller (BET) gas adsorption isotherm and 
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nuclear magnetic resonance (NMR), and the determination of the stability in a 
dispersion via Zeta potential measurements [24]. 
 
1.3.3 OECD Working Party on Nanotechnology 
In March 2007, the Organisation for Economic Cooperation and Development 
(OECD) helped establish a division that had the sole purpose of giving advice in 
relation to emerging issues in science, technology and innovation streams for the 
responsible use and development of NT. The OECD Working Party on Manufactured 
Nanomaterials concentrates on nanomaterial research and what implications if any, 
may be associated with the use of manufactured nanomaterials, specifically in 
relation to human and environmental effects. The main aim of this group [25] was to 
create an international standard to ensure that risk, hazard and exposure assessments 
are harmonised. In doing so, they initiated a sponsorship programme to test a variety 
of manufactured nanomaterials. Countries involved in the testing (known as sponsor 
countries) conducted a plethora of tests that included characterisation, environmental 
fate, ecotoxicological and toxicological tests. The various NPs investigated and the 
countries involved in this program are summarised below in Table 1.1.  
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Table 1.1. Summary of the particles investigated as part of the OECD testing 
programme and the countries involved. 
NP Type  Lead Sponsor Co-sponsor Contributors 
Fullerenes (C60) Japan, US - Denmark, China 
Single-walled 
Carbon 
nanotubes 
Japan, US - Germany, Canada, EC, France, China, BIAC 
Multi-wall 
Carbon 
nanotubes 
Japan, US Korea Germany, Canada, EC, France, China, BIAC 
Silver  US, Korea 
Germany, Canada, 
Australia, Nordic 
Council of Ministers 
EC, France, China, BIAC, 
Netherlands 
Iron  China  Canada, US, Nordic Council 
of Ministers 
Titanium dioxide  France, Germany 
Austria, Canada, 
Spain, Korea, US China, Denmark, Japan, UK 
Aluminium  - - Germany, US, Japan 
Cerium Oxide UK, US Netherlands, Spain, Australia 
Germany, EC, Switzerland, 
Denmark, Japan 
Zinc Oxide UK Australia, US Canada, Germany, Denmark, Japan, Netherlands, Spain 
Silicon dioxide  France Belgium, Korea Denmark, Japan 
Gold South Africa Korea, US EC 
Dendrimers  Spain, US Austria, Korea 
 
1.3.4 Nanotoxicology and Nanoparticle Exposure 
Whilst NPs have a wide range of suitable applications, the field will always be 
hindered by public perception and the safety surrounding their use. Although the 
field of toxicology has been established for many years, only recently has the field of 
nanotoxicology come to fruition. In 2005, Oberdörster et al. [26] described 
nanotoxicology as an emerging discipline in the “science of engineered nanodevices 
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and nanostructures that deals with their effects in living organisms”. In this article, 
they crucially pointed out the importance of nanotoxicological research in providing 
the essential safety evaluations for engineered nanomaterials and associated devices, 
and how we as researchers can apply this knowledge to make safer nanomaterials in 
the future. Another vital reason for safety evaluations is that the ever growing field of 
NT is likely to become a major source of human exposure (particularly from the use 
of engineered NPs), and the ability of NPs to be inherently different compared to 
bulk forms with regards to exposure routes is at the forefront of this. The main routes 
of exposure with regards to NPs are via ingestion, inhalation and dermal routes (see 
Figure 1.4).  
 
 
 
 
 
 
 
 
 
Figure 1.4. Human exposure routes to NPs include ingestion, inhalation and dermal. 
1.3.4.1 Oral Exposure 
The gastrointestinal tract (GIT) is a highly specialised barrier exchange system for 
obtaining nutrients and expelling waste. Whilst it may not be obvious, ingested 
material is a major route of exposure to TiO2 NPs, particularly to those containing 
 Ingestion 
Skin 
Inhalation 
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whitening agents such as Mentos and Whipped cream frosting [27]. Not surprisingly 
is that the extent to which NPs might be absorbed via the GIT is reliant on common 
factors such as the size, surface charge and concentration of the NPs [28]. Szentkuti 
et al. [29] established that the rate of NP diffusion across the mucosal layer to the 
surface of the enterocytes was dependent on size and surface charge. Briefly, 
positively-charged latex particles were trapped by the negatively-charged mucous, 
whilst repulsive carboxylated fluorescent latex particles were free to diffuse across 
the layer. Smaller sized particles were shown to penetrate the mucosal layer at a 
faster rate than larger sized particles, with 14 nm particles reaching the enterocytes in 
2 min while the 1 µm particles were unable to diffuse across the barrier. Similar 
studies showing these types of results indicate that NPs would not remain in the GIT 
for a lengthy amount of time, with roughly 98% being eliminated via the faeces and 
2% via urine [30]. Whilst there are studies suggesting a large proportion of ingested 
NPs are eliminated from the body, it is important to realise the potential for NPs 
being translocated to other organs, such as the spleen, liver, lungs and brain via the 
GIT [31-33]. 
1.3.4.2 Inhalational Exposure 
Exposure to incidental NPs via inhalation is probably the most prominent way by 
which humans are exposed to these particulates [9]. As such it is virtually impossible 
to not have been exposed to NPs via this route. Dust storms are a major 
environmental producer of NPs, producing particles up to 100 nm in size, which can 
be especially detrimental for individuals suffering from respiratory diseases [34]. 
Other natural sources of NPs include forest fires and volcanic eruptions, producing 
airborne ash particulates [9]. A common inhalation source of NPs includes diesel 
exhaust particulates, which can exist in the 20-130 nm size range. This size range has 
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been shown to induce adverse health effects, particularly having an influence on 
mortality with epidemiological studies showing a correlation between high exposure 
levels and the mortality of those living near highways [35]. When NPs are inhaled, 
their fate is dependent on the characteristics that make them unique, such as size and 
surface area. NPs can be deposited throughout the respiratory tract from the 
nasopharyngeal to the alveolar regions [12]. When this occurs the body’s defence 
mechanisms are activated to keep the mucosal surfaces free from NP deposits. One 
such mechanism is chemical dissolution, by which particles that are soluble (e.g. 
lipid-based) may be diffused into the fluid lining the epithelial layer and 
subsequently absorbed and cleared into the blood [36]. In contrast to this is a more 
“physical” approach, which is different depending on the location along the 
respiratory tract [37]. For example, macrophages are important for removing 
particulate matter within the alveolar regions of the tract. Another important 
“physical” mechanism is the mucociliary escalator by which particulate matter is 
removed via the movement of mucous upward from the bronchioles to the larynx and 
out of the respiratory tract [9]. However this can also result in swallowing the 
particulate matter, thus resulting in exposure to the GIT. 
1.3.4.3 Dermal Exposure  
The skin is the main barrier to all foreign material and it aids in the protection of 
internal organs, waterproofing the body, regulating temperature (sweating) and is 
important for Vitamin D synthesis. It is composed of three main layers that differ in 
thickness at different regions of the body; the epidermis, the dermis and the 
hypodermis. Figure 1.5 illustrates the many layers of the epidermis which is 
composed of stratum basale, stratum spinosum, stratum granulosum, stratum lucidum 
(only found on palms of hands and soles on feet) and the stratum corneum [38]. 
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Figure 1.5. Haemotoxylin and eosin stained human skin section indicating the 
different epidermal layers and dermis [38]. 
 
The basal layer (stratum basale), consists of rapidly proliferating and differentiating 
keratinocytes, Merkel cells and melanocytes [39, 40]. The stratum spinosum, which 
lies directly above this layer, contains Langerhans cells that protect the skin against 
infection [39]. The stratum corneum (the uppermost layer) contains cornified 
keratinocytes that have migrated from the stratum basale [39]. The dermis is made up 
of three major cell types, i.e. adipocytes, fibroblasts and, macrophages; whilst the 
hypodermis is composed mainly of loose connective tissue and adipocytes [39]. In 
addition to the important function of protecting the internal organs from foreign 
matter, the skin also confers protection against the harmful effects of UV radiation.  
 
1.4 Ultraviolet Radiation 
UV radiation is part of the electromagnetic spectrum that is emitted from the sun and 
comprises three different types of UV radiation (Figure 1.6): UVA (320-400 nm), 
UVB (280-320 nm), and UVC (100-280 nm) [41].  
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Figure 1.6. Electromagnetic spectrum of sunlight. 
UV radiation is of particular interest as it can significantly affect biological systems. 
In terms of the energy produced by the different forms of radiation, it forms an 
inverse relationship to its wavelength, with UVC having a higher level of energy 
than that of UVB and UVA, respectively [42]. However due to the stratospheric 
ozone layer filtering out wavelengths of light below 290 nm, we are not exposed to 
UVC and part of the UVB range. As such, the proportion of UV light that reaches the 
Earth comprises ~95% UVA and ~5% UVB [43]. Sunlight is not the only source 
from which we may be exposed to UV light. Artificial sources of UV light include 
arc welding lamps and tanning beds, so whilst we are not exposed to UVC light from 
the sun itself, individuals who undertake arc welding may be exposed to this form of 
UV radiation. This occurs because arc welding produces the entire spectrum of UV 
radiation [44]. As such, these individuals need to take extra precautions in protecting 
their skin and eyes from the harmful effects of UVC.  
Interest surrounding the use of tanning beds has increased recently. In 2009, the 
International Agency for Research on Cancer labelled tanning beds as being 
carcinogenic to humans. The dangers surrounding the use of tanning beds and 
growing health concerns led the Victorian and New South Wales state governments 
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within Australia to legislate against their use by 2015 [45]. Whilst it is known that 
there are detrimental effects from being exposed to UV light, some of which will be 
discussed in detail later on, it does play a beneficial role in phototherapy and Vitamin 
D production.  
 
1.4.1 Phototherapy 
Phototherapy is used to treat skin conditions such as psoriasis and vitiligo [46]. In 
short, the plant-derived phototoxin psoralen is usually given in conjunction with 
UVA and UVB exposure on the affected skin surface, and it functions by decreasing 
the activation of lymphocytes and epidermal cells thereby reducing the inflammatory 
response. Whilst this form of treatment has been shown to be beneficial, there is 
conflicting evidence as to the chronic effects that patients may incur, with one study 
showing that long-term treatment increased the risk of non-melanoma skin cancers  
from UVA treatment [47], whilst another study showed that patients treated with 
UVA showed no such mutations, but did show mutations from UVB exposure [48].  
 
1.4.2 Vitamin D
 
Production 
Vitamin D is essential for healthy bone function and calcium absorption [49]. Whilst 
some is obtained from dietary intake, this level alone is insufficient. The best source 
comes from UV light exposure. Briefly, UVB converts 7-dehydrocholestrol in the 
skin to cholecalciferol (Vitamin D3). Vitamin D3 undergoes hydroxylation in the 
liver to produce 25-hydroxycholecalciferol through the action of 25-hydroxylase.  
25-hydroxycholecalciferol is further hydroxylated in the kidneys to produce  
1,25-dihydroxycholecalciferol (active Vitamin D hormone) via the action of  
20 
 
1α-hydroxylase [50]. Whilst there are clear benefits to UV exposure for those with 
specific disorders and deficiencies, for the general public they are completely 
outweighed by the health risks and side effects it may cause. 
 
1.5 UV Effects on Skin 
UV radiation is considered an environmental carcinogen and its effect on skin differs 
depending on a number of factors that include: skin type, exposure type (i.e. UVA or 
UVB), exposure time and age. When looking at the individual components of UV, 
the shorter wavelength UVB only penetrates into the epidermis, whilst the longer 
wavelength UVA penetrates into the underlying dermis as shown in Figure 1.7. 
Figure 1.7. Simplified haemotoxylin and eosin stained skin section depicting the 
ability of UVA and UVB to penetrate into the skin [51]. 
 
One of the main variances of UV exposure in humans is the differences in the 
response of different skin types. Classified according to the Fitzpatrick scale, there 
are six different groups that people fall into based on their skin colour, ability to burn 
and ultimately their risk of skin cancer [52]. This is summarised in the Table 1.2 
below. 
Epidermis 
Dermis 
Sun 
UVB UVA 
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Table 1.2. Comparison of the different Fitzpatrick skin types summarising their skin 
colour, ability to burn and to develop skin cancer [52].  
Skin 
Type Skin Colour Ability to Burn Risk of Skin Cancer 
1 Very pale white Always burns, never tans Greatest risk 
2 Fair white  Burns easily, minimal tan High risk 
3 Light brown Burns moderately, sometimes tans High risk 
4 Moderate brown Burns minimally, usually tans Moderate risk 
5 Dark brown Rarely burns, tans easily Low risk 
6 Dark brown to black Hardly burns, tans very well Low risk  
 
The effects of UV exposure can range from acute effects that present clinically as 
erythema and pigmentation, to chronic effects that clinically include photoageing and 
carcinogenesis. Whilst the aforementioned effects are usually generalised for UV 
exposure as a whole, the extent of the effects differ depending on the type of UV 
exposure, i.e. either UVA or UVB.  
 
1.5.1 UVA-specific Effects 
UVA is of a longer wavelength range than UVB and is considered to be less 
erythemogenic [53]. Interestingly, the erythema caused by UVA has been reported to 
be a biphasic response. This biphasic response has been described as an erythema 
that appears within seconds of UVA exposure, followed by a delayed erythema that 
peaks from minutes to hours later [53, 54]. However, this response was most 
noticeably seen in those individuals possessing type 1 and 2 skin [55]. Other studies 
have conflicted with this viewpoint, and only showed the erythemogenic response to 
be monophasic and dependent on the dose of UVA received [56].  
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In terms of generating a visibly identifiable erythema, this would most likely only 
occur in type 1 skin and the intensity of the erythema would be much higher [55]. 
Applegate et al. [57] observed this result when they compared a range of UVA doses 
on people with skin types 1-4. They also observed that the ability to generate 
erythema is largely dependent on the location of skin exposure as this related to the 
frequency of UVA exposure [57]. When comparing the forearms and buttocks of the 
individuals, the erythema generated on the forearms was barely detectable, whereas 
the erythema generated on the buttocks was highly noticeable.  
In terms of generating pigmentation of the skin, UVA is more effective in inducing 
pigment darkening than it is at generating erythema [53]. The different types of 
pigment darkening induced by UVA include, immediate pigment darkening (IPD), 
persistent pigment darkening and delayed tanning [58]. It is thought that the IPD 
response is caused by the “redistribution of melanosomes and photo-oxidation of 
melanin that is already present in the skin”, rather than synthesis of new melanin [53, 
59]. Delayed tanning is a slower process, usually appearing within a few days after 
exposure and, depending on exposure and skin type of the individual, may last for 
months [60, 61].  
At the molecular level, the effects observed between UVA and UVB exposure also 
differ. As UVA can penetrate into the deeper layers of the dermis, it is able to excite 
various chromophores, such as flavins, DNA and RNA, which can lead to the 
generation of reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), 
hydroxyl radicals (•OH) and singlet oxygen [62]. This is thought to occur via two 
different pathways, as follows. In simple terms, Type 1 reactions involve an excited 
photosensitiser reacting with a substrate (DNA, RNA), resulting in hydrogen atoms 
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or electron transfer that yields radicals or radical ions. Type 2 reactions involve the 
direct transfer of energy from the excited photosensitiser to an oxygen molecule [62, 
63]. The ROS produced by this pathway can also cause DNA damage, resulting in 
the formation of oxidative products such as 7,8-dihydro-8-oxo-guanosine [55, 64].   
 
1.5.2 UVB-specific Effects 
UVB is highly erythmogenic and has a minimal erythemal dose some 1000-fold less 
than that of UVA [61]. This is largely dependent on the skin type of the individual, 
with darker skin types needing higher doses of UVB to induce a minimal erythema 
[65]. However, Henrikson et al. [65] demonstrated that consecutive UV exposures 
led to the erythemal dose being lowered in the dark skinned subject group, but not in 
the fair skinned subject group. Furthermore, the erythema produced in dark skinned 
individuals was present for a shorter amount time when compared to lighter skinned 
individuals, being three days and two weeks, respectively [53, 65]. The skin 
pigmentation response to UVB exposure also includes delayed tanning [61, 66]. As 
with the UVA response, the ability for UVB to produce a minimal erythemal 
response is largely dependent on the exposure length and the region of the body that 
is exposed [61, 67].  
At the molecular level, the erythema produced by UVB exposure is caused by 
vasodilation of the blood vessels in the dermis, and it is thought that this response 
occurs via release of certain cytokines, histamine and prostaglandins, to essentially 
elicit an inflammatory response [53]. However, one of the main molecular effects 
produced by UVB exposure is the generation of DNA lesions in the form of 
cyclobutane pyrimidine dimers and 6-4 photoproducts [48, 68]. These are considered 
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to be the direct effects of UVB exposure. Overall, the direct and indirect damage to 
DNA resulting from sunlight exposure is most likely the starting point in the 
generation of skin cancer, but only if DNA repair and removal of the photoproducts 
is incomplete.  
 
1.6 Skin Cancer 
Skin cancer is the ultimate consequence of UV exposure. Australia has one of the 
highest incidences of skin cancer in the world, with two in three Australians being 
diagnosed with some form of skin cancer by the time they are 70 years old [69]. In 
Australia alone, skin cancers account for 80% of all newly diagnosed cancers. 
Alarmingly the cost of treating non-melanoma skin cancers is projected to jump from 
$500 million in 2010 to around $700 million in 2015 in Australia alone, creating a 
huge burden on the health care system [70]. There are three types of skin cancer: 
basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and malignant 
melanoma (MM). BCC and SCC are generally grouped together into non-melanoma 
skin cancers (NMSC). The most common of the NMSC is BCC which accounts for 
70% whilst SCC accounts for 30%.  Although NMSC are more common in 
comparison to MM, they are often considered to be less aggressive with early 
treatment resulting in better outcomes for the patient, however this does not suggest 
all patients treated for NMSC will survive.  
Skin cancer develops over time and involves a complex network of pathways that 
essentially do not work the way they are meant to. As mentioned earlier, UV 
radiation generates DNA lesions and photoproducts, which if not repaired could lead 
to mutations and subsequently this may give rise to cancer [55]. In order to prevent 
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this from happening, cells contain mechanisms to either repair or prevent these 
damaged cells from replicating [71]. Simply, upon UV radiation, the DNA damage 
that occurs can cause the cell cycle to arrest at the G1 or G2 checkpoints [55, 71, 72]. 
This then allows the DNA to be repaired by a number of repair pathways, before it is 
duplicated during replication phase. A crucial protein involved in this process is p53 
[73, 74], which is also one of the most commonly mutated genes in cancers and is 
activated by cellular stresses. It also serves the function of acting as a transcription 
factor, to regulate target genes [75, 76].  
Under normal circumstances, DNA damage caused by UV radiation leads to 
increased production of the p53 protein, which induces transcription of p21 [55]. The 
p21 protein exerts its affects by inhibiting the enzymes required for cell cycle 
control, i.e. cyclin dependent kinases [74, 75]. Inhibition of these cell cycle control 
enzymes can be beneficial as it leads to cell cycle arrest at the G1 checkpoint, thus 
allowing mutated DNA to be repaired. If however the DNA cannot be repaired, 
apoptotic pathways become activated [55, 74, 77].  
 
1.7 Cytokines and UV Exposure 
Cytokines refers to any protein-like mediators that are released during an 
inflammatory response and are essentially involved in its coordination [78]. Whilst 
they are usually always present at low concentrations, they can become upregulated 
in response to various stimuli such as UV radiation [76]. A number of different 
cytokines have been noted to be released by the various cells in the epidermis and 
dermis in response to stimuli, including IL-1, IL-4, IL-6, IL-8, IL-10, IL-12, IL-15 
and Tumour Necrosis Factor (TNF) α [79]. IL-6 is of particular importance as it 
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plays a variety of roles, such as mediating the acute phase response, inducing fever 
and is important for B-cell growth and differentiation [80]. These are some of the 
roles by which IL-6 exerts it effects in immune responses and inflammation, and is 
thus why it is thought to play an important role in the skin’s response to UV 
exposure.  
 
1.8 Generation of Reactive Oxygen Species 
ROS are generated intracellularly via the redox reactions involved during 
mitochondrial respiration, however they can also be generated extracellularly as is 
the case in activated immune cells. In order to remove these ROS, cells contain 
inherent protective mechanisms, such as superoxide dismutase (SOD) and catalase, 
to limit the potential damage that may be caused by ROS [81]. However, if these 
innate mechanisms become overwhelmed, it may lead to oxidative stress within these 
cells. The common ROS that are produced are the superoxide anion (O2•-), H2O2 and 
•OH. ROS have been implicated in causing oxidative DNA damage, which is one of 
the mechanisms thought to be involved in the formation of skin cancer [82]. As 
mentioned earlier, UVA is mainly associated with direct ROS generation, however 
there is evidence that suggests UVB exposure can also do the same. A study by 
Portugal-Cohen et al. [83] observed that by exposing human skin explants to UVB 
light, ROS was generated in a dose dependent manner up to 2 kJ/m2.   
It is clear that the effects that UV exposure has on our skin, both cellularly and 
structurally, can be detrimental if measures are not taken to protect ourselves. In 
order to minimise these effects, organisations such as the Cancer Council of Victoria 
and Sunsmart have ongoing campaigns warning people of the harmful effects of 
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unprotected UV exposure [84, 85]. The general consensus is that the use of 
sunscreens is one of the best ways to reduce skin damage from UV radiation [84].  
 
1.9 Sunscreens 
Sunscreens were developed to provide photoprotection to the skin from the harmful 
effects of UV radiation. Historians believe the use of a topical agent to protect the 
skin, goes back as far to the Ancient Egyptians, where having lighter coloured skin 
was considered more attractive, so they applied certain agents to the skin to prevent 
the skin darkening [86]. The first effective and practical sunscreen was created by 
Franz Greiter in 1938, who would later develop the sun protection factor (SPF) in 
1962 [87]. SPF is a laboratory measure of the UVB-filtering efficacy of a sunscreen 
and is now considered a worldwide standard. SPF 15+ is capable of filtering out at 
least 93% of the UVB rays, whereas SPF 30+ filters out at least 97%. The 
effectiveness of sunscreen not only depends on the SPF, but also the frequency of 
sunscreen application and whether or not an individual is engaging in certain 
activities, such as swimming. It is recommended that sunscreens be applied 20 min 
before an individual is exposed to the sun and subsequently reapplied after every two 
hours [84]. The recommended amount of sunscreen that should be applied is 2 
mg/cm2 of body area [87]. 
Sunscreens contain formulations of UV filters that are able to absorb or reflect UV 
radiation. Currently, there is a set concentration that is allowed for each UV filter in 
Australia and New Zealand (Table 1.3), as with many countries. These 
concentrations are determined by the various regulatory bodies in each country, i.e. 
the Therapeutic Goods Administration in Australia, and the Food and Drug 
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Administration in the USA [87]. There is no consensus between countries as to what 
amount of each filter should be allowed in sunscreen formulations, and even the 
packaging and labelling of sunscreen products differs between countries. This 
situation recently changed in Europe, whereas of July 2013, manufacturers must 
display in their labelling whether lipsticks, creams and sunscreen formulations 
contain NPs [88]. No such legislation has yet been passed in Australia with regards 
to mandatory labelling for products containing NPs. Similarly, permissible SPF 
upper limits are another measure that differs between countries. Australia only 
allows sunscreens to feature a maximum SPF of 50+, whereas in the Europe, SPF 
60+ is allowable. 
Sunscreen UV filters tend to be divided into two groups depending on their active 
ingredients: (a) organic chemical UV filters that absorb UV light, and (b) physical 
(inorganics) UV filters, which absorb and reflect UV light [89]. Many high SPF 
sunscreen formulations contain a mixture of both chemical and physical UV filters. 
 
Table 1.3. Maximum concentrations of UV filters allowed in sunscreens for use in 
Australia and New Zealand [87]. 
UV Filter % Maximum Concentration 
Octyl salicylate 5 
Homosalate 15 
Octyl methoxycinnamate 10 
Butyl methoxydibenzoylmethane 5 
TiO2 25 
ZnO No limit 
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1.9.1 Chemical Sunscreens 
Organic chemical sunscreens typically contain organic-based molecules that possess 
an aromatic ring bearing two specific functional groups, i.e. one that will donate and 
one that will accept electrons, following exposure to UV radiation [90]. In general, 
the chemical sunscreens have a narrow UV filtering range and only confer protection 
in the UVB or UVA range. Figure 1.8 shows the broad spectrum capabilities of 
chemical and physical UV filters commonly used in sunscreens. Compared to the 
chemical UV filters, only ZnO shows complete broad spectrum UVA and UVB 
filtering characteristics.  
 
 
 
 
 
 
 
Figure 1.8. UV spectrum blocking capabilities of commonly used sunscreen 
ingredients [91]. 
 
Chemical sunscreens have also been shown to be photo-unstable, becoming 
inactivated by UV radiation and thus losing their photo-protective effects [92]. There 
can also be a hypersensitivity response produced by the chemical sunscreens only 
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after UV exposure has occurred, however the degree to which this occurs is unclear 
[93]. This might be because the reported causes of the hypersensitivity have changed 
over time as new sunscreen formulations have been developed [93]. In the early 
1980s, concerns were raised about the use of para-aminobenzoic acid, with 
documented reports detailing the allergic response to this chemical [93, 94]. In the 
1990s, benzophenone-3 was the most common chemical sunscreen that caused 
photoallergenicity [95]. Whilst most of the reported complications to chemical 
sunscreens include sensations of stinging and burning, true contact hypersensitivity is 
considered rare [96-98]. Chemical sunscreens have also been noted to penetrate 
through the skin [99-102]. The degree to which this occurs differs depending on the 
location of sunscreen application on the body, concentration of the chemical, and if it 
is co-used with solvents, such as formulations containing insecticides [100, 101]. It 
should be noted however, that there is no current evidence to suggest that the 
absorbed ingredients in the chemical-based sunscreens will lead to harm. In fact, all 
chemical UV filters had to pass extensive safety testing before approval was given 
for marketing, as decreed by the various regulatory bodies (e.g. FDA and TGA).  
 
1.9.2 Physical Sunscreens 
The term physical sunscreen is attributed to those formulations which contain ZnO 
and TiO2. They are given that name as they essentially act as a physical barrier to UV 
radiation. Larger sized forms of these particles have been incorporated into 
sunscreens for many years. However, due to their uniformed white appearance on the 
skin they lacked aesthetic appeal [54, 89]. On the other hand, metal oxide NP 
formulations are transparent, making them cosmetically more favourable whilst still 
retaining their broad-spectrum UV filtering ability, however this is really only seen 
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in particulates ≤ 30 nm in size [89, 103]. Figure 1.9 shows a comparison by Cross et 
al. [89] of the ability to absorb UV/Visible light for three differently-sized ZnO 
particulates. They demonstrated that regardless of size, ZnO served as a good filter of 
UV light in the UV range. However, the differences between the particles arose in 
their ability to transmit visible light, i.e. when placed on the skin do they appear clear 
or opaque? As the size of the particulates decreases, their ability to transmit visible 
light increases, while still retaining their broad spectrum UV-filtering capability. 
Another beneficial claim to the use of physical UV filters is that due to their relative 
inertness, they are considered to be photostable and there is no evidence of irritation 
and sensitisation on intact human skin [104, 105].  
It is these features of metal oxide NPs that have been exploited and subsequently 
generated some hype in the community. As these particles are so small, concern has 
also been raised as to whether they may penetrate the skin [106]. 
 
 
 
 
 
 
 
 
Figure 1.9. UV Absorption profile for different sizes of ZnO [89]. 
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To date (Dec. 2013), no studies have shown that NPs found in sunscreens can 
significantly penetrate the epidermal layers of human skin. Whilst most studies 
conclusively agree that penetration does not occur beyond the stratum corneum, only 
one study has showed the presence of Zn2+ from ZnO particulates in the blood and 
urine of human subjects after sunscreen application and co-exposure to sunlight 
[107]. In this hallmark study, volunteers were exposed to ZnO sunscreen 
formulations for the purposes of determining if the rare stable isotope form of Zn2+ 
from the sunscreen particulates were being absorbed through the skin. Two different 
types of Zn-based sunscreens were used in this study, a nano form and a bulk form. 
The results from this study indicated that the amount of Zn detected in the blood and 
urine after nano and bulk sunscreen exposure were a thousandth of the levels of Zn 
that are naturally present, suggesting that the amount of Zn absorbed through the skin 
was negligible [107].  
Filipe et al. [108] recently investigated the dermal penetration of TiO2 and ZnO NPs 
in damaged human skin. Using punch biopsy analysis and tape stripping they found 
that beyond the stratum corneum, there were negligible amounts of titania particles 
present, whilst Zn levels were similar to untreated skin (i.e. measurable Zn levels 
were similar to what was already present in the body).  
 
1.9.3 Molecular Effects of Sunscreen Nanoparticles 
Whilst it is evident that sunscreen formulations of metal oxide NPs do not readily 
penetrate beyond the stratum corneum of human skin, it is important to understand 
the potential effects they may pose if they could penetrate into damaged skin. Some 
studies have looked at the effects of metal oxide NPs on human dermal fibroblasts 
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and HaCaT keratinocytes cells [109-111]. In general, most agree that high 
concentrations of ZnO NPs are cytotoxic to cultured cells. However, the mechanism 
by which this occurs is not well understood. There are some studies, including 
reports from our own research group, outlining the mechanism of ZnO cytotoxicity 
in vitro and attributing it to ROS generation and/or intracellular Zn2+ release [112-
116]. Jeong et al. [117] showed that the levels of cytosolic ROS and mitochondrial 
ROS, tested by 2’,7’-dichlorodihydrofluorescein diacetate (DCF-DA) and MitoSOX 
Red respectively, both increased from untreated controls in HaCaT cells treated with 
ZnO NPs of around 30 nm in size. Shen et al.  [112] found that ZnO NPs increased 
both mitochondrial ROS and cytosolic ROS production in THP-1 monocyte cells. 
Furthermore they found that while ROS formation can be mitigated with antioxidants 
such as Vitamin C and E, they had no overall effect on improving cell viability. So 
although Zn2+ ions are not redox active like the transition metal ions of Fe and Cu, 
which can directly promote ROS generation via Fenton chemistry, high 
concentrations of Zn2+ ions are still able to increase intracellular ROS production by 
disrupting several cellular processes.  
ROS are not the only factors that have been attributed to cause cytotoxicity. Some 
studies suggest that Zn2+ released from ZnO NPs may also play a role [118-123]. It is 
believed that when NPs are taken up by the cell, they end up inside endosomes. Due 
to the acidic nature of the endosomes, the ZnO NPs start to dissolve and shed Zn2+ 
[120]. This produces an increase in free intracellular Zn2+ in the cell that is thought to 
contribute towards the cytotoxic effect of ZnO NP exposure [120, 122].  
The consequence of intracellular Zn2+ release is that this may induce perturbation of 
the mitochondrial membrane potential, as observed by Sasidharan et al. [121] and 
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Buerki-Thurnherr et al. [120] in a breast adenocarcinoma cell line (MCF-7) and a 
human leukaemic T-lymphocytic (Jurkat) cell line, respectively. Muller et al. [123] 
also observed significant structural changes to mitochondria from ZnO nanocrystal 
exposure in human macrophages that they attributed to an increase in intracellular 
Zn2+ release. Furthermore, Xia et al. [122] demonstrated that by iron-doping the ZnO 
NPs, the intracellular dissolution potential of the particulates was reduced along with 
the cytotoxic effect. However, it still remains unclear as to whether the cytotoxicity 
caused by ZnO NP exposure is a result of: (a) intracellular Zn2+ release which 
induces ROS production via its effects on mitochondria; or (b) intracellular Zn2+ 
overload alone. One mechanism that cells use to maintain Zn2+ homeostasis is to 
utilise metallothioneins (MTs) [124]. MTs are metal-binding proteins capable of 
binding Zn2+. This binding is heavily dependent on the acid/base equilibrium, with 
changes in redox state either facilitating binding (reducing agents) or promoting 
release (cellular oxidants) [124, 125]. Furthermore, any extra cytosolic Zn2+ may also 
be sequestered into the mitochondria [126]. Under normal conditions, this process 
serves a homeostatic control mechanism for Zn within the cell, however, if this 
process is overloaded it may result in mitochondrial dysfunction and oxidative stress. 
Excess Zn2+ ions have been shown to interfere with the electron transport chain by 
inhibiting complex III at cytochrome bc1 and complex I by inhibiting α-ketoglutarate 
dehydrogenase [127, 128]. This has the combined effect of promoting mitochondrial 
ROS generation. These ROS may then oxidise the Zn-binding thiol groups of MTs to 
interfere with their binding of Zn2+, causing Zn2+ release from the MTs and thus 
increasing the level of free Zn2+ in the cell [124]. This subsequent release of Zn2+ 
may then go on to cause the generation of further ROS, by the aforementioned 
processes.  
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ZnO NP exposure may also activate cell death pathways, such as apoptosis and 
necrosis. What is not clear is by which specific pathway this occurs. Buerki-
Thurnherr et al. [120] observed that ZnO NP exposure in Jurkat cells shifted from an 
apoptotic mode of cell death at early exposure time-points (5 h), to a late 
apoptotic/necrotic cell death at later exposure time points (15-48 h). These findings 
are supported by Wilhelmi et al. [129] who observed a similar result in a mouse 
leukaemic monocyte macrophage (RAW 264.7) cell line. De Berardis et al. [130], 
observed that ZnO NP exposure in colon carcinoma cells (LoVo) caused apoptotic 
cell death at the highest concentration tested (80 µg/mL). Similarly, a study by 
Sharma et al. [131], showed that ZnO NPs induced apoptotic cell death pathways in 
human liver cells (HepG2), as measured by a decrease in mitochondrial membrane 
potential, activation of caspase 9 and Bax proteins; all of which are associated with 
the mitochondrial pathway of cell death [131]. This pathway is commonly known as 
the intrinsic apoptotic cell death pathway. From the information at hand, it is still 
unclear as to which specific cell death pathway is activated from ZnO NP exposure, 
however it would most likely differ when comparing cell type and length of 
exposure. 
Apart from ZnO, another metal oxide commonly used in sunscreens is TiO2 (also 
termed ‘titania’).
 
TiO2 particulates are classified as biologically inert and have been 
heavily used in cosmetics [110]. Recently however, advances in the NT industry 
have led to the widespread use of TiO2 particulates in their nano form. Current uses 
for nano TiO2 are in paints, inks, rubber, cement and sunscreens [132]. This 
usefulness stems from the ability of titania particulates to have inherent absorbing 
and deflecting UV filtering properties, and also the ability to act as a semiconductor 
[133]. Nevertheless, it is these inherent properties that are thought to be linked to 
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their potential for toxicity. Following UVA irradiation, electrons in the TiO2 crystal 
absorb the photon energy and jump to a higher electron state, causing an electron gap 
known as a “band hole” [110]. These band holes have the ability to extract electrons 
from water or hydroxyl ions to generate ROS in the form of •OH. As aforementioned 
with ZnO NPs, the formation of ROS is thought to be a contributing factor of 
cytotoxicity from TiO2 NP exposure.  
Yin et al. [110], showed that TiO2 NP co-exposure with UVA-radiation caused 
significant cytotoxicity in HaCaT cells, and attributed this effect to the formation of 
ROS from UVA exposure. Interestingly, when the cells were exposed to TiO2 NP 
and UVA separately, they did not generate significant cytotoxicity from control cells, 
even at doses of 100 µg/mL and 10 J/cm2, respectively. Conversely, studies by 
Jaeger et al. [134] and Tucci et al. [132] showed that TiO2 did not generate any 
significant cytotoxicity in HaCaT cells. Whilst there is no complete consensus on 
whether or not TiO2 exposure is capable of inducing cytotoxicity, it is accepted that 
TiO2 NPs are capable of producing ROS in the presence of UV.  
 
1.10 Conclusion 
The field of nanotoxicology is an important area of emerging research due to an ever 
growing NT industry. It is important that whilst we develop new technologies, there 
is a parallel focus on the safe use of these nanomaterials. Our skin is the primary 
barrier and first line of defence to all foreign matter. Therefore it is important that 
whilst we are using sunscreens to protect our skin, that we also understand the 
potential effects that they may have on our skin. Although there have been some 
studies on the effects of sunscreen NPs on skin explants and skin cells, more 
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mechanistic work still needs to be done. For example, determining the mechanisms 
behind cell death is important so that we can better understand the nature of these 
individual NPs and their bioactivities, as different modes of cell death have different 
consequences for surrounding tissues and cells. This information is vital so that we 
can formulate better and safer NP-containing products, but more importantly, so that 
the public can also feel “safe” in using such nanoproducts. 
Consequently, the research project described in this thesis involved a mechanistic 
investigation using an in vitro exposure system of a model human skin cell line, to 
generate information that will form the basis of future in vitro testing assays in 
primary skin cells, as well as the more complex in vivo assays in human skin 
explants. This project focussed on the in vitro effects of NPs on human keratinocyte 
HaCaT cells in both the presence and absence of UV radiation. A range of ZnO-
based particulates were investigated that included a surfactant coated and bulk form, 
as well as a ZnCl2 control. These were also directly compared to two different TiO2 
based NPs. Therefore, I hypothesised that different types of Zinc and TiO2 based 
particulates would show dose dependent cytotoxicity and that this would correlate 
with an increase in ROS and intracellular Zn2+ ion production.   
The endpoints measured in the project included: cytotoxicity of the various 
particulates to HaCaT cells; intracellular production of ROS from NPs and/or UV co-
exposure; generation of intracellular Zn2+ ions from NPs as a possible mechanism of 
cell death, and finally the cell death pathways via apoptosis and necrosis. The 
outcomes generated from this thesis provide a greater understanding of the in vitro 
effects on HaCaT cells of co-exposure to UV and ZnO or TiO2 NPs.  
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In this project, I aimed to: 
1. Determine if particulate exposure, with/without UV co-exposure, causes 
cytotoxicity to HaCaT cells;  
2. Determine if particulate exposure affects the release of bioactive molecules, 
such as cytokines; 
3. Determine if ZnO NP exposure generates changes in intracellular Zn2+ levels; 
4. Determine if NP exposure generates intracellular ROS, such as mitochondrial 
superoxide and peroxides; 
5. Determine if ZnO NP exposure causes cytotoxicity by inducing apoptotic or 
necrotic pathways.   
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Chapter 2 Materials and Methods 
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2.1 Materials 
The following chemicals and biochemicals were used in this study: Roswell Park 
Memorial Institute (RPMI) phenol red containing, and also phenol red-free, medium 
1640, its Penicillin-Streptomycin-Glutamate additions, and Trypsin-EDTA solution 
were obtained from Invitrogen (Melbourne, Australia). Foetal bovine serum (FBS) 
was obtained from SAFC Biosciences (Melbourne, Australia). Phosphate-buffered 
saline (PBS) tablets, Hank’s Buffered Salt Solution (HBSS), Zinquin ethyl ester 
(Zinquin), DCF-DA, MitoSOXTM Red mitochondrial superoxide indicator for live 
cell imaging (MitoSOX) and 0.4% (w/v) Trypan Blue solution and propidium iodide 
(PI) were obtained from Sigma (Sydney, Australia). The CellTiter® AQueous One 
solution Cell Proliferation Assay (MTS) was obtained from Promega (Melbourne, 
Australia). Human Th1/Th2 11-plex FlowCytomix Multiplex kit was obtained from 
Bender MedSystem (Vienna, Austria). OptEIATM Set Human IL-6 ELISA kit was 
obtained from BD Biosciences (San Jose, USA). Annexin V- fluorescein 
isothiocyanate (FITC) Apoptosis Detection Kit (also contains PI) was obtained from 
Beckman Coulter (Sydney, Australia). 
The following lab-ware were used in this study: 75cm2 canted-neck tissue culture 
flasks were obtained from Corning (Corning, USA); 24-well plates were obtained 
from ThermoFischer Scientific (Scoresby, Australia); and 96-well flat bottom 
microtest plates were obtained from Starstedt (Adelaide, Australia).  
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2.2 Cell Line and Culturing Techniques 
2.2.1 Cell Line 
The HaCaT (immortalised human keratinocyte) cells [135] used in the experiments 
were kindly supplied by Professor Peter Parsons (QIMR, Brisbane, Australia). All 
solutions used in the series of experiments described within this thesis were pre-
warmed to 37°C unless stated otherwise.  
2.2.2 Cell Culture 
All cell culture work described in this thesis was performed under sterile conditions 
in a NuAire Class II Biohazard Safety Cabinet (Plymouth, USA) unless stated 
otherwise. The HaCaT cells were cultured with RPMI-1640 media that had been 
supplemented with 5% (v/v) FBS and 1% (v/v) Penicillin-Streptomycin-Glutamine 
(hereafter termed “tissue culture media”). Spent culture media was removed every 
three to four days and replaced with fresh tissue culture media. The cultures were 
maintained in 75 cm2 tissue culture flasks and placed in a humidified, 5% CO2 cell 
culture incubator that was maintained at 37°C. Media used for culturing cells 
contained phenol red for the purpose of indicating pH, whereas the media used in 
experiments did not contain phenol red (known as “phenol red-free media”). The 
reasoning behind this is that the phenol red absorbs UV radiation, which may give a 
lower UV dose.  
Cultures were deemed confluent enough to commence experiments when the cells 
covered roughly 70-80% of the flask base. This was determined via a visual 
inspection through an inverted microscope and was usually reached in three to four 
days. New cultures were established via the addition of about 0.5-1 mL of cell 
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suspension to new flasks containing approximately 20-25 mL of fresh tissue culture 
media. 
2.2.3 Cell Harvesting 
When confluence was reached (~70-80%), spent culture media was discarded and the 
cells washed twice with 2 mL PBS. After which, the cells were washed quickly with 
1-2 mL of Trypsin-EDTA. After this pre-wash, the cells were incubated with 3 mL 
Trypsin-EDTA for 3 min in the incubator at 37°C to dislodge the cells. In order to 
maximise dislodging of the cells, the flask was tapped gently. Dislodged cells were 
resuspended two to three times and used for sub-culture and experimentation, as 
described below.   
2.2.4 Cell Stock Preparation for Experiments 
In order to ensure reproducibility between experiments, 3 x 104 cells were added to 
each well in a 24-well plate. Following cell harvesting (section 2.2.3), the trypsinised 
cells were placed in a centrifuge tube, along with twice the volume of phenol red-free 
media. Following centrifugation (300 g for 5 min at room temperature), the 
supernatant was discarded and the cells resuspended in 1 mL of phenol red-free 
media. The cell number was determined using trypan blue exclusion. Briefly, to 25 
µL of cell suspension, 25 µL of 0.4% w/v trypan blue solution was added. This 
mixture was gently mixed and a 25 µL aliquot removed and placed in a 
haemocytometer to count the cells using a light microscope (Leica, Diaplan, 
Germany). The amount of cells that was required for the experiments was diluted to 
3 x 104 cells/mL with phenol red-free media, and 1 mL of this volume added per well 
in a 24-well plate. In all studies described in this thesis, the cells were allowed to 
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adhere to a 24-well plate for 24 h at 37oC in a 5% CO2 incubator, prior to the start of 
the experiment unless stated otherwise.  
 
2.3 Nanoparticles Investigated 
The NPs investigated in this project were: ZnO NPs of 30 nm, without (i.e. pristine 
NPs, denoted “ZnO 30”) or with (denoted “sZnO 30”) a surfactant dispersant 
(approximately 5% by weight of Orotan 731 DP, a sodium polyacrylate), supplied by 
Micronisers Pty. Ltd. (Melbourne, Australia); a larger pristine ZnO NP (denoted “Z-
Cote”) from BASF (Germany); a bulk form of ZnO (denoted “ZnO Bulk”) from 
Sigma Aldrich (UK); and TiO2 NPs of anatase and rutile crystalline form (denoted 
“TiO2–Anatase” and “TiO2–Rutile”, respectively). Three of the ZnO particulates 
were test materials used in the OECD nanosafety testing program, i.e. ZnO 30 
(OECD test material NM-112), Z-Cote (NM-110) and ZnO Bulk (NM-113). ZnCl2 
was also used to serve as a Zn ion-based control.  
Below is a summary of the characterisation of all NPs used in the experiments 
described in this thesis. All NP characterisation procedures were conducted at the 
National Measurement Institute, Sydney, Australia by members of our research 
group and collaborators [136], however I duly acknowledge that this work was not 
conducted by myself.  
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Table 2.1 Summary of particulate characterisation conducted at the National 
Measurement Institute. 
Particle 
Primary  
Particle Size 
(nm) 
Agglomerate size 
(Disc centrifuge, in 
media) 
Specific Surface 
Area (Mean BET) 
(m2/g) 
ZnO 30 
36 ± 6 (DLS) 
25 ± 7 (TEM) 1.01 µm (0.60-1.68 µm) 27.2 ± 1.2 
sZnO 30 ** 75 nm (50-100 nm) n.d. 
Z-Cote 
Width: 44 ± 12 
Length: 73 ± 3 
(TEM) 
1.10 µm (0.66-1.46 µm) 12.4 ± 0.6 
ZnO Bulk 
200-500 (DLS) 
200-600 (TEM) 0.95 µm (0.58-1.61 µm) 6.2 ± 0.3 
TiO2–Anatase 25 ± 3 (TEM) 102 nm (51-195 nm) n.d. 
TiO2–Rutile 34 ± 3 (TEM) 219 nm (95-379 nm) n.d. 
CeO2 10 ± 3 (TEM) 50 nm (25-100 nm) n.d. 
DLS = dynamic light scattering. TEM = Transmission Electron Microscopy. 
* surfactant NPs have same particle size as pristine NPs; “n.d.” = not determined. 
 
 
2.3.1 Nanoparticle Preparation 
Particulates used for the experiments were weighed out and suspended in Milli-Q 
water at a final concentration of 20 mg/mL. This mixture was then sonicated for 5 
min to sterilize and disperse the particles in that mixture. These “stock” solutions 
were then left to stand for 24 h at room temperature prior to use. The stock solutions 
were then vortexed for ~30 sec and then the tubes inverted 10-20 times until the 
particulates were resuspended. Particulate “working solutions” were then made up by 
pipetting out the required amount of “NP stock” and adding to culture media to 
achieve the desired concentration.  
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2.4 Ultraviolet Irradiation Procedure 
HaCaT cells were exposed to UV radiation using a BioSpectra UV cabinet (Vilber 
Lourmat, France). The machine has an interface which allows for specific doses 
(UVA or UVB) to be programmed, as well as an inbuilt UV detector. This allows for 
reproducibility of UV doses between experiments. 
UVA- and UVB-irradiations (UV-irradiated) were done sequentially in all 
experiments described in this thesis. The outputs of the UV lamps were measured 
using an inbuilt photometer and the UV effective doses were determined, as outlined 
in Table 2.2 below. Furthermore, the UV doses used in the studies described in this 
thesis achieved a minimal erythemal dose (MED) of 1.0 for UVB and the equivalent 
of 0.5 for UVA. One MED is the minimal dose that is required to cause reddening on 
the skin. Thus this UV dose of 1 MED UVB or 0.06 J/cm2 and 0.5 MED UVA  or 
1.20 J/cm2 represents a physiological exposure that might be received by a person 
who has been in the noonday summer sun for 30 min in Sydney, Australia at 33.86°S 
latitude [137]. 
Table 2.2 UVAB doses administered to cells.  
UV type UV Dose (J/cm2) Exposure Time (s) 
UVA 1.20 MED 270 
0.5 
UVB 0.06 1.0 39 
UVA + UVB (1.20 + 0.06) (270 + 39) 
 
In order to observe the effect of combined UV radiation, the cells were exposed to 
both UVA-and UVB-radiation (UV radiation). To observe the effect of co-exposure 
to UV and NPs, the UV irradiation was done immediately following the addition of 
NPs at the UV doses described in Table 2.2. Cells that were not exposed to UV 
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radiation are called sham-irradiated. Plates containing cells to be UV-irradiated were 
placed in the centre console tray of the UV cabinet and exposed to the respective UV 
doses. After UV-irradiation took place, both the sham- and UV-irradiated plates were 
placed into the incubator for 23.5 h at 37°C, 5% CO2. 
 
2.5 Cytotoxicity Assay 
Cytotoxicity was determined by observing the change in the viability of cells that had 
been exposed to a dose range of NPs in the presence and absence of UV radiation. 
Cell viability was measured as the percentage of live cells against untreated controls 
at 4, 8, 12, 16, 20 and 24 h time points, using the MTS assay. The supernatants from 
these experiments were also analysed for cytokine levels (section 2.6). 
2.5.1 Nanoparticle Exposures 
Working solutions were prepared from stock solutions described in section 2.3.1, to 
achieve final incubation concentrations typically ranging from 0-100 µg/mL. In each 
of the assays, cells were either treated with NPs or used as untreated controls (no 
NPs, with media alone). A maximum of 500 µL was added to each well. All 
exposures were done in triplicates.  
2.5.2 Absorption Measurements 
At 23.5 h post-UV exposure, the plates were removed from the incubator and 250 µL 
of media was removed from each individual well and placed into a 96-well plate, and 
stored at -80oC before being analysed for cytokine levels. The remaining media (250 
µL) was discarded and replaced by 300 µL of fresh phenol red-free media. 60 µL of 
MTS solution was added to each well and the plate was returned to the 37°C 
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incubator. After 30 min, 240 µL of this media was removed and added to a 96 well 
plate and the absorbance was measured at 490 nm. 
 
2.6 Cytokine Profiling 
Cytokine profiling was performed, with the kind assistance of Dr Bryce Feltis, using 
a FACSCanto Flow cytometry system and the human Th1/Th2 11-plex FlowCytomix 
Multiplex kit, as per the manufacturer’s instructions. This kit was chosen because it 
allowed us to measure 11 cytokines simultaneously, i.e. IL-1β, IL-2, IL-4, IL-5, IL-6, 
IL-8, IL-10 and IL-12p70, TNFα and β, and Interferon-γ. 
The multiplex kit showed that IL-6 was the only cytokine released from the HaCaT 
cells in response to the NP and UV exposures in our test system. Therefore, the IL-6 
levels were quantitated in the stored frozen media samples (see section 2.5) by 
further assaying using a specific ELISA. These samples were first allowed to thaw 
and a 50 µL aliquot was prepared and assayed as per the manufacturer’s instructions 
in the BD Biosciences OptEIATM Set Human IL-6 ELISA kit.  
 
2.7 UV Absorbance Spectral Analysis of Particles 
In order to determine how the NPs may directly affect the UV exposure in our 
system (e.g. by their dispersion characteristics and the regions that they may absorb 
in the UV-spectrum), the NPs were analysed by a UV-spectrometer under identical in 
vitro exposure conditions (but in the absence of cells) using UV-transparent 
microplates. Spectral profiles of the NPs were measured in both media and water at 
48 
 
concentrations ranging from 0-3000 µg/mL over the wavelength range of 200-800 
nm.  
 
2.8 Measurement of Intracellular Zinc Ion Levels  
Intracellular zinc levels were measured after loading the cells with zinquin ethyl 
ester, which is a lipophilic derivative of zinquin [138]. Once inside the cell, cytosolic 
esterases cleave the ethyl ester group to release the Zn2+-specific fluorophore 
zinquin, which also prevents its efflux across the plasma membrane. 
2.8.1 Preparation and Measurement of Zinquin 
Zinquin was supplied from the manufacturer as a powder and made up into 25 mM 
stock solutions via the addition of dimethylsulfoxide (DMSO). These were diluted in 
phenol red-free media to a final concentration of 150 µM prior to use. HaCaT cell 
cultures are seeded (section 2.2.4) and treated with NPs as described earlier (section 
2.5.1). After 23.5 h incubation with NPs, 100 µL of 150 µM Zinquin solution was 
added to each well, resulting in a final concentration of 25 µM. The plates were then 
incubated at 37oC in a 5% CO2 incubator for 30 min. At the end of this period, the 
media was removed and then cells washed with 200 µL of PBS. The cells were 
detached as described earlier (section 2.2.3) with the following modifications. A total 
volume of 200 µL of Trypsin-EDTA was added to each well and left to incubate for 
5 min at 37oC in a 5% CO2 incubator. Once the cells had detached, 400 µL of cold 
(4oC) fresh phenol red-free media containing 5% FBS was added to every well to 
inactivate the Trypsin-EDTA. This ensured that the cells were in a stable 
environment whilst being analysed on the flow cytometer, as incubating with 
Trypsin-EDTA for too long would kill the cells. 
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The detached cells are then added to individual flow cytometry tubes and centrifuged 
at 300 g for 5 min at 4oC in preparation for analysis on the flow cytometer. After 
which, the supernatants were discarded and the cell pellets resuspended in 300 µL of 
cold (4oC) phenol red-free media. The tubes were kept on ice (~30 min) until they 
were ready to be analysed by flow cytometry (see section 2.8.2). 
2.8.2 Data Analysis for Zinquin Flow Cytometric Assays  
The effect of particulate and/or UV exposure on HaCaT cells was measured as using 
the upper limit setting of 10,000 events, or maximal events after 3 min per tube. The 
reason for this is that cultures exposed to high doses of NPs generally have low cell 
viability and cell numbers overall, so the events in those tubes may never reach 
10,000 when assayed via the flow cytometer. Nonetheless, the events for each 
sample tube was exported from the BD FACSDiva™ software and imported into 
Excel for analysis. For the Zinquin assays, the mean fluorescence intensity of the 
events was exported. Each treatment (particle type, concentration, sham or UV 
irradiated) was performed in triplicate for each experiment, and the mean ± standard 
error (SEM) calculated from the means of these experiments. Data was represented 
as the average fold increase from the sham-irradiated control.   
 
2.9 Measurement of Intracellular ROS Levels  
2.9.1 Measurement of Mitochondrial Superoxide Levels in HaCaT cells 
In order to measure superoxide production in the treated cells, a fluorescent indicator 
was used, i.e. the MitoSOX™ Red mitochondrial superoxide indicator for live-cell 
imaging.  Stock solutions of MitoSOX Red (5 mM, as supplied by the manufacturer) 
were stored at -20oC for all experiments. A 2.5 µM working solution was prepared 
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by diluting the stock solution in HBSS. Cultures of HaCaT cells grown in 24-well 
plates were established, as described in section 2.2.4. Prior to the cells being treated 
with NPs and/or exposed to UV radiation, they were washed with 200 µL of PBS 
after which 250 µL of 2.5 µM MitoSOX Red was added to each well for 30 min. At 
the end of this period, the MitoSOX Red reagent was removed and cells washed 
twice with 200 µL of PBS. The cells were then treated with NPs and/or UV radiation 
as described (sections 2.4 and 2.5.1). A positive control was also used in the form of 
a xanthine/xanthine oxidase system for generating a superoxide radical flux (i.e. 3.33 
mM xanthine, 1 mM EDTA, 10 mM potassium phosphate buffer, phenol red-free 
media and 5 µL of 4 U/mL xanthine oxidase). Following this, the media in the plates 
was removed and cells washed with 200 µL of PBS. The cells were then detached as 
described (section 2.8.1). 
The detached cells were added to flow cytometry tubes and centrifuged at 300 g for  
5 min, 4oC in preparation for flow cytometric analysis. The supernatants were 
discarded and the cell pellets resuspended in 300 µL of cold (4oC) phenol red-free 
media. The tubes were kept on ice for 30 min until they were analysed by flow 
cytometry. 
The effect of particulate and/or UV exposure on HaCaT cells was measured as using 
the same event settings as described in section 2.8.2, as well as the number of 
replicates and reporting of data.   
2.9.2 Measurement of Intracellular Peroxide Levels in HaCaT cells 
The fluorescent probe 2’,7’-dicholorofluoroscein (DCF) is capable of measuring 
ROS in the form of peroxides [139]. Initially, the non-fluorescent 2’,7’-
dichlorodihydrofluoroscein diacetate (DCF-DA) is deactylated by cellular esterases 
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to 2’,7’-dichlorodihydrofluoroescein (DCFH). This compound becomes trapped in 
the cells and is converted to the fluorescent DCF in the presence of peroxidases. 
DCF-DA was supplied from the manufacturer as a powder and made up into 100 
mM stocks via the addition of DMSO and stored at -20°C until needed. A working 
solution of 10 µM was prepared from the initial stock solution by diluting it in HBSS 
prior to use. Cultures of HaCaT cells grown in a 24-well plate were established as 
previously described in section 2.2.4. Prior to the cells being treated with NPs and/or 
exposed to UV radiation, they were washed with 200 µL of PBS and 250 µL of 10 
µM DCF-DA was added to each well and incubated at 37oC, 5% CO2 for 30 min in 
the dark. At the end of this period, the liquid in the well containing the DCF-DA was 
discarded and cells were washed twice with 200 µL of PBS. Cells were then treated 
with NPs and/or UV radiation as previously described (sections 2.4 and 2.5.1). After 
24 h, the media in the wells was removed and the cells washed in 200 µL of PBS. 
The cells were then detached as described (section 2.8.1). 
The detached cells were added to flow cytometry tubes and centrifuged at 300 g for 5 
min at 4oC in preparation for flow cytometric analysis. The supernatant was 
discarded and cell pellet resuspended in 300 µL of cold (4oC) phenol red-free media. 
The tubes were kept on ice for 30 min until they were ready to be analysed by flow 
cytometry.  
The effect of particulate and/or UV exposure on HaCaT cells was measured using the 
same event settings as described in section 2.8.2, as well as the number of replicates 
and reporting of data.   
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2.10 Measurement of Apoptosis and Necrosis  
The staining kit containing Annexin V-FITC conjugate and PI was used to determine 
the cell death pathways occurring in HaCaT cells that had been exposed to NPs 
and/or UV radiation. 
Annexin V is a ligand that avidly binds to phosphatidylserine (PS) that is present on 
the inner side of the cell membrane until membrane phospholipids are scrambled 
during apoptosis, while the vital dye PI binds to the DNA and RNA of cells that have 
a damaged membrane [140]. The assay was performed according to the 
manufacturer’s instructions. Briefly, cultures of HaCaT cells were grown in a 24-
well plate (section 2.2.4), before being treated with NPs and/or UV radiation as 
previously described (sections 2.4 and 2.5.1). After 24 h, the media in the plates was 
removed and cells washed and then detached, as previously described (section 2.8.1). 
After this, the detached cells in the plates were added to flow cytometry tubes and 
centrifuged at 300 g for 5 min at 4oC in preparation for flow cytometric analysis. The 
supernatant was then removed and the pellet resuspended in 100 µL of binding 
buffer, as per the manufacturer’s instructions. The cells were then incubated with 
Annexin V-FITC and PI for 15 min on ice in the dark, after which 400 µL of binding 
buffer was added to each tube and kept on ice and in the dark prior to being analysed 
by flow cytometry within 30 min. 
The effect of particulate and/or UV exposure on HaCaT cells was measured using the 
same event settings as described in section 2.8.2. Cell counts were divided into 
subpopulations to easily measure the percentage of debris, viable, early apoptotic and 
late apoptotic/necrotic cells. The number of events from each quadrant was then 
exported from the BD FACSDiva™ software and imported into Excel for analysis. 
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Each quadrant was expressed as a percentage of the total cell population. The results 
were presented as the average ± SEM for triplicate samples.  
 
2.11 Statistical Analyses  
All assays were conducted as 3 replicate experiments in triplicate unless stated 
otherwise, and the mean ± SEM was determined across the experiments. Statistical 
analyses were performed by applying two-way analyses of variance (ANOVA) with 
Bonferroni multiple comparisons test, when comparing between particles at different 
concentrations. When comparing concentrations and particulates back to the control 
mean value, a two-way ANOVA with Dunnett’s test was applied. All statistical tests 
were performed using GraphPad Prism version 6.02 for Windows, GraphPad 
Software, La Jolla, USA. 
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Chapter 3 – In vitro cytotoxicity and 
cytokine expression in HaCaT human 
keratinocytes exposed to zinc oxide and 
titania particulates 
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3.1 Introduction 
An important component in any toxicological study involves in vitro testing. It is 
extremely useful because it allows investigators to determine appropriate exposure 
ranges that can be transferred to in vivo models and also ascertain the mechanistic 
effects of the test materials at the cellular level [141].   
One of the first end-points in any in vitro toxicological investigation is to determine 
the cytotoxicity of the test materials in the specified test system [141]. Cytotoxicity 
testing provides a basic understanding of how the test materials of interest (in this 
case, ZnO and TiO2 particulates) interact with the test system. Keratinocytes are the 
main cell type found in the epidermis and are more likely to be exposed to these NPs. 
For this in vitro exposure system, HaCaT cells were chosen as a model human 
keratinocyte cell line, as their differentiating capacity and growth characteristics are 
similar to that of primary keratinocytes [142, 143]. Furthermore, HaCaT cells have 
been shown to display a relatively stable genetic balance over extensive culturing 
periods, without shifting to a tumourigenic phenotype [144]. It should be noted that 
HaCaT cells possess molecular alterations such as a dysfunctional p53 gene which 
may have an effect on cell signalling and cytokine expression [135, 145].  
These cells were exposed to a range of concentrations of the different particulates, 
thereby allowing the formulation of dose response profiles that can be utilised for 
further toxicological end-points.  
There are numerous ways that cytotoxicity can be measured in vitro and these 
different methods usually rely on either the metabolic function or membrane integrity 
of the cells being measured. An extremely common and widely used cell viability 
assay is the CellTiter 96® AQueous One Solution Cell Proliferation Assay [112, 
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116, 146-148]. This assay employs a soluble tetrazolium compound (MTS; 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium), which is bioreduced by cells to produce a coloured formazan product 
that absorbs light at 490 nm. This conversion involves an NADH dependent 
mechanism in the mitochondrial electron transport chain [149]. The MTS assay is a 
measure of cell viability, based on their mitochondrial activity.  
In this project, the MTS assay was used to assess the cytotoxicity of the seven 
different particulates, as described previously in section 2.5. HaCaT cell viability 
was initially measured after 24 h of exposure to ZnO and TiO2 particulates using the 
MTS assay, after which a time course of cell viability using the MTS assay was also 
measured at 4, 8, 12, 16, 20 and 24 h following exposure to ZnO particulates. The 
range of ZnO and TiO2 particulate concentrations described in this thesis are shown 
in Table 3.1. 
Table 3.1 ZnO and TiO2 particulate exposure concentrations 
 
 
 
HaCaT  Cells 
Particulate Dose Range (µg/mL) 
ZnO 30 1-100 
sZnO 30 1-100 
Z-Cote 1-100 
ZnO Bulk 1-100 
TiO2 Anatase  1-5000 
TiO2 Rutile 1-5000 
ZnCl2 (Zn2+ control) 1-100 
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Another useful end-point utilised for in vitro toxicological testing is the generation of 
an immune response. In response to a pathogen, cells can secrete proteins called 
cytokines [150]. Cytokines are intercellular signalling molecules used by cells to 
coordinate an immune response to stresses, such as infection or injury. Cytokines are 
grouped based upon their biological function: (a) ILs, which alter the behaviour of 
leukocytes; (b) interferons, which interfere with viral replication and activate 
immune cells; and (c) the TNF family, which can help the immune system to combat 
cancers [151, 152]. These proteins play an important role in an immune response, as 
the release of a specific cytokine in response to stimuli ultimately determines the 
path of the overall immune response. These pathways are divided into three different 
T-cell based responses and characterised not only based on the different kinds of T 
cells that are involved and their respective pathways, but also by the specific set of 
cytokines that are produced by each pathway [153].  
The T-helper 1 (Th-1), T-helper 2 (Th-2) and T-helper 17 (Th-17) pathways are 
based on the specific response that they induce due to the specific cytokines 
involved. Furthermore, the responses generated via the different pathways are 
antagonistic towards one another, in that a response from one pathway supresses the 
other pathway [154].  
Th-1 responses are intracellular-based responses directed at viral, fungal and 
bacterial infections, and are stimulated via IL-12 release from antigen presenting 
cells [155]. This results in the release of further cytokines, such as interferon-γ and 
IL-2 [150]. Secretion of IFN-γ can stimulate pro-inflammatory processes, such as 
phagocytosis, the activation of macrophages, and upregulation of antigen presenting 
cells [156]. 
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Th-2 responses are extracellular-based responses directed at pathogens such as 
parasitic worms [155]. Th-2 responses are stimulated via IL-4 release, which in turn 
suppresses other Th-based pathways [150]. Cytokines produced via the Th-2 
pathway are responsible for the regulation of B-cells, eosinophils, basophils and 
macrophages [157]. 
In the skin, the immune response generated is not only dependent on immune events 
occurring locally in the skin, but also elsewhere, such as the activation of draining 
lymph nodes [87]. In response to a pathogen, Langerhans cells as the epidermal 
phagocytes, are stimulated and ingest the pathogen. The Langerhans cells then 
migrate towards the draining lymph node due to TNF-α stimulation and mature into 
dendritic cells in the process. Here they interact with CD4+T cells, which then 
differentiate into the T-helper cells and induce either a Th-1 or Th-2 responses. It is 
well known that UV-radiation can induce immunosuppression and that this can be 
caused via different molecular pathways [158-162]. It is thought that the process 
leading to UV-induced immunosuppression is initiated via chromophores, which are 
substances capable of absorbing light, in this case UV light. The main endogenous 
chromophores found in human skin are DNA [163], trans-urocanic acid [160] and 
less defined membrane components [164]. When these chromophores absorb UV 
light, structural changes occur within the substance itself leading to the induction of 
mediators, such as platelet activating factor [165]. This mediator can further induce 
prostaglandin release via the binding of receptors on monocytes, macrophages and 
keratinocytes [165]. Following this is the release of immunosuppressive cytokines, 
such as IL-4 and IL-10 [166]. The overall effect of UV-radiation on these 
chromophores is the induction of changes in antigen presentation, which leads to 
immunosuppression [163].  IL-6 is a pro-inflammatory cytokine released from 
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epidermal keratinocytes cells after stimulation by UV-radiation [79]. Furthermore it 
has been shown that exposure of skin cells to silver [167], ZnO [116] and TiO2 NPs 
[168] can also induce immunomodulatory effects via simulating the production of 
pro-inflammatory cytokines, such as IL-6, IL-8 and TNF-α. 
In this chapter, MTS was used to assess the cytotoxic effect of different ZnO and 
TiO2 particulates on HaCaT cells over a broad concentration range. Cell viability was 
assessed after 24 h of exposure to the different particulates, in the presence and 
absence of UV radiation. Additionally, the cytokine release profile was assessed by 
multiplex flow cytometry, and the main cytokine response (IL-6) generated from 
particulate and/or UV radiation exposure was accurately quantitated via the ELISA 
assay.  
 
3.2 Results  
In order to evaluate cell viability using the MTS assay, it was important to optimise 
the test system being investigated. This involved determining the appropriate number 
of cells per well in a 24-well plate, as well as the specific incubation time following 
the addition of MTS to the cell culture. These factors depend heavily on the level of 
mitochondrial activity of the particular cell type that is under investigation.  
In all the experiments with HaCaT cells, the cells were first allowed to adhere to the 
flat-bottom surface of the wells for 24 h after seeding, before being exposed to UV-
radiation and/or particulates, and subsequently incubated for a further 24 h before the 
endpoints were assessed. For this reason, it was important that a suitable cell seeding 
density was chosen to generate the appropriate confluency at the end timepoint of the 
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experiment for the untreated control wells. HaCaT cells were seeded into a 24-well 
plate at a range of cell densities and the level of confluency was determined visually 
under a light microscope. The cell densities measured were 1.5, 3.0, 4.5 and 6.0 x 104 
cells per well. The optimal seeding density was found to be 30,000 cells by visual 
inspection.  
In order to determine the optimum conditions for the MTS assay, cell numbers per 
well as described above were used and incubated for 48 h. MTS was added to the 
wells and the relative absorbance was measured after incubation times of 30 min, 1 
h, 1.5 h and 2 h. As shown in Figure 3.1, MTS absorbance began to plateau after 1 h 
incubation time (for ≥3.0 x 104 cells per well), reaching a maximal absorbance of ~2 
absorbance units. Therefore an MTS incubation time of 30 min was deemed most 
appropriate as the absorbance profile was still following a linear response for most of 
the cell concentrations tested.  
 
 
 
 
 
 
 
 
 
Figure 3.1. MTS assay optimisation for HaCaT cells. Data represented as the mean ± 
SEM of one experiment conducted in triplicate. 
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3.2.1 Effect of UV radiation on HaCaT cell viability  
In order to determine the effect that UV radiation had on the HaCaT cells, they were 
exposed to 1.26 J/cm2 of UVAB radiation (0.5 MED UVA and 1 MED UVB) and the 
cell viability was measured over a 24 h period, according to the procedure described 
in sections 2.4 and 2.5. Exposure to UV radiation caused a ~50% decrease in cell 
viability over 24 h (Figure 3.2). Furthermore, this decrease in cell viability was not 
an instantaneous event occurring immediately after UV-exposure, but rather a 
progressive one that takes place over a 24 h period. Additionally, the decrease in cell 
viability was found to be significantly different to control from 8 h onwards, post 
UV-exposure (p<0.05).  
 
 
 
 
 
 
 
 
Figure 3.2. Viability of UV-irradiated HaCaT cells over 24 h. Data represents the 
mean ± SEM of 2 replicate experiments conducted in triplicate. 
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3.2.2 UV-visible absorption profiles of the particulates in water and media 
To assess how the particulates may directly affect the UV exposure in our in vitro 
test system, different concentrations (1-1000 µg/mL) of NPs in both water (Figure 
3.3) and media (Figure 3.4) were assessed using a UV-visible spectrophotometer 
over the UV (200-400 nm) and visible (400-800 nm) spectrums (as described in 
section 2.7). Absorption profiles of the particulates in water indicate that as the 
concentration of the particulates increased, their absorption increased, with the more 
dispersed particles producing the greatest increases in light absorption. In terms of 
which particulates were better dispersed in water, it was found that the two TiO2 
particles were better dispersed than any of the ZnO particulates. When comparing the 
ZnO particulates, sZnO 30 was found to be better dispersed in water than any of the 
other ZnO particulates. Whilst the various particulates in water were found to be 
dispersed to different degrees (based on absorbance units), they all followed the same 
trend in their absorption over the UVA, UVB and UVC wavelength ranges.  
Interestingly, absorbance profiles of particulates in phenol red-free culture media, 
showed similar dispersive results to that described above in water. The only 
difference in the absorbance profiles of particulates in water and media is that the 
presence of proteins and amino acids in media generated two distinct peaks in the 
UVB and UVC regions, respectively. As was seen in water, the two TiO2 particles 
were better dispersed than any of the ZnO forms. Furthermore, sZnO 30 was again 
better dispersed in media than any of the other tested ZnO particulates. 
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Figure 3.3. UV-visible absorption profiles of the effects of different concentration of particulates in water. 
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Figure 3.4. UV-visible absorption profiles of the effects of different concentration of particulates in phenol red-free media.
65 
 
3.2.3 Effect of 24 h exposure to particulates on HaCaT cell viability 
Cytotoxicity of the different particulates to HaCaT cells was assessed using the MTS 
viability assay after 24 h of exposure. In vitro cytotoxicity testing is one of the first 
end-points determined in any toxicological investigation and thus was used to 
measure the relative tolerance of HaCaT cells to different particulates. Furthermore, 
it was also used to produce a smaller dose range of particulate exposure that could be 
used for the more complex flow cytometry assays described later in this thesis. 
Since the particulates investigated in this study are commonly found in commercial 
sunscreens, it is important to know what effects they may have on skin cells, in 
particular keratinocytes. The cells were cultured and exposed to particulates and/or 
UV radiation as previously described (sections 2.4 and 2.5). Cell viability was 
assessed after 24 h of exposure using the MTS viability assay and is seen in Figure 
3.5. No significant differences in cell viability were seen between the different 
particulates at low concentrations (0-3 µg/mL) in the sham-irradiated cells (Fig 
3.5A). At higher concentrations however some noticeable differences were observed. 
At 10 µg/mL in the sham-irradiated cells, Z-Cote and ZnO Bulk were the least 
tolerated (p<0.05) of all the particulates. However, at 30 µg/mL the sZnO 30 
particulate was the least tolerated (p<0.05) of all the zinc species. Apart from ZnO 
Bulk, all the ZnO particulates were cytotoxic at 100 µg/mL. Overall, the larger sized 
ZnO particulates were different to control cells at concentrations ≥10 µg/mL, while 
in the smaller sized ZnO particulates, this occurred at higher concentrations (≥30 
µg/mL) (p<0.05). 
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Figure. 3.5. Viability of HaCaT cells exposed to ZnO and TiO2 particulates for 24 h. 
(A) Dose response of sham-irradiated HaCaT cells exposed to particulates; (B) Dose 
response of UV-irradiated HaCaT cells exposed to particulates. Data represents the 
mean ± SEM of 3 replicate experiments conducted in triplicate. Significant 
differences were determined by two-way ANOVA with Bonferroni’s post-hoc test.  
* different to all other particulates at the same concentration, # different to control   
(p < 0.05). 
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In comparison, both TiO2 particulates over the concentration range of 0-100 µg/mL 
were significantly better tolerated by the cells when compared to the other 
particulates. Furthermore, whilst anatase was found to have no significant effect on 
cell viability, rutile particulates were found to cause a significant decrease in cell 
viability at 30-100 µg/mL compared to sham-irradiated control. 
When HaCaT cells were exposed to UV radiation, cell viability was decreased by 
~50% when compared to sham-irradiated control cells as seen in Figure 3.5B.  
At 10 µg/mL, ZnCl2, ZnO Bulk and Z-Cote were the least tolerated particulates in 
the irradiated cells. Moreover, when compared to the UV-irradiated control cells, all 
of the ZnO particulates were found to cause significant cytotoxicity at concentrations  
≥10 µg/mL (p<0.05). At concentrations ≥30 µg/mL, TiO2 particulates were better 
tolerated than all zinc-based particulates, however only anatase had no significant 
effect on cell viability across the entire dose range (0-100 µg/mL). 
Since the titania NPs were far less cytotoxic than the ZnO particulates over the 
concentration range chosen (0-100 µg/mL), the experiments were extended to 
include higher doses. Cell viability was assessed at 24 h following exposure to titania 
NPs over a broad concentration range (0-5000 µg/mL) and measured using the MTS 
viability assay (Figure 3.6). It can be seen that TiO2 particulates were still well-
tolerated by both sham- and UV-irradiated HaCaT cells, even at 5 mg/mL. When 
TiO2 was added to the sham-irradiated HaCaT cells at doses ≥1 mg/mL, the viability 
appeared to increase from 47% to 52% with TiO2 anatase treatment, and 57% to 80% 
with TiO2 rutile treatment (Figure 3.6A). A similar effect was noticed in UV-
irradiated HaCaT cells (Figure 3.6B), where at doses ≥1 mg/mL, the viability 
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Figure. 3.6. Viability of HaCaT cells exposed to high doses of TiO2 NPs for 24 h. 
(A) Dose response of sham-irradiated cells exposed to particulates; (B) Dose 
response of UV-irradiated cells exposed to particulates. Data represents the mean ± 
SEM of 3 replicate experiments conducted in triplicate.   
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appeared to increase from 19% to 42% with anatase treatment and 25% to 77% with 
the rutile treatment, irrespective of the ~50% decrease in cell viability caused by UV 
radiation alone. These unusual results were most likely caused by the optical 
interference that was produced by the NPs at such high concentrations. In order to 
reduce this effect, we centrifuged the plates which minimised particulate interference 
up to the 1 mg/mL dose. However, at the higher concentrations (3-5 mg/mL), this 
proved to be most difficult as any slight movement of the plate caused the easily-
dispersed particles to become unsettled and thus interfere with the assay. 
Whilst the previous data (Figure 3.5) showed that higher doses of ZnO particulates 
on HaCaT cells was almost completely cytotoxic after 24 h of exposure, it is 
important to investigate how the time course of the cell viability changes over this 24 
h period. Therefore, the effect of ZnO particulates (0-100 µg/mL) on HaCaT cell 
viability was measured at different time-points over a 24 h period, as seen in Figure 
3.7. Titania particulates were not investigated in this time course study as they did 
not cause the extent of cytotoxicity generated by ZnO particulates.  
At 10 µg/mL in sham-irradiated cells, ZnO Bulk particulates were the least tolerated 
particles from 8 h onwards (p<0.05), causing a time-dependent decrease in cell 
viability (Figure 3.7A). All other particulates at this same concentration were 
tolerated by the cells over the 24 h period, with no significant differences observed 
between particulate-exposed cells or the untreated controls.  
At 30 µg/mL in the sham-irradiated cells, differences were detected between the 
cytotoxic effects elicited by the particulates after 12 h (Figure 3.7B).  sZnO 30 was 
found to be less tolerated by HaCaT cells than any other particulate treatments, being 
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Fig 3.7. Time course of the effects of ZnO particulates on the viability of sham-irradiated HaCaT cells. Cells were exposed to 10 (A), 30 (B) and 
100 (C) µg/mL of particulates. Data represents the mean ± SEM of 2 replicate experiments conducted in triplicate. Significant differences were 
determined by two-way ANOVA with Bonferroni’s post-hoc test. * different vs. all other particulates; everything below the dotted line is 
significantly different to control (p < 0.05).
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significantly different to the similarly sized ZnO 30 from early time-points (12-24 h), 
and significantly different to the larger sized Z-Cote and ZnO Bulk particulates at the 
later time-points (20-24 h). Differences in the treated cells from the untreated control 
cells (Figure 3.7B) were observed from 12 h onwards for all particulates except for 
Z-Cote (p<0.05).  
When the sham-irradiated cells were exposed to particulates at 100 µg/mL (Figure 
3.7C), ZnO Bulk was the most tolerated particulate from 8 h onwards, followed by 
Z-Cote. It should be noted that the effect elicited by ZnO Bulk at 100 µg/mL, is 
different to that seen at 10 µg/mL, suggesting that ZnO Bulk is better tolerated at 
higher concentrations by HaCaT cells. Whilst this result is unusual, it does support 
unpublished data generated by our group showing similar result in HaCaT cells using 
a ZnO 200 nm particulate. However, this phenomenon would need to be further 
investigated. Furthermore, the smaller sized particulates were found to cause a time-
dependent decrease in cell viability from 8 h onwards, while the larger-sized 
particulates of Z-Cote and ZnO Bulk caused time-dependent decreases from 12 and 
20 h, respectively. This is in contrast to what occurred at lower concentrations  
(10-30 µg/mL), with decreases in cell viability occurring earlier, from 8 h onwards.  
In the UV-irradiated HaCaT cells, UV radiation alone, caused a 50% decrease in cell 
viability in a time-dependent manner by 24 h. All particulates at 10 µg/mL elicited a 
further time-dependent decrease in cell viability after 8 h, which was significantly 
different to that seen in the untreated UV-irradiated control (p<0.05) (Figure 3.8A). 
No differences were observed between these particulates at 10 µg/mL in UV-
irradiated cells. 
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Fig 3.8. Time course of the effects of ZnO particulates on the viability of HaCaT cells co-exposed to UV-irradiation. Cells wereexposed to 10 
(A), 30 (B) and 100 (C) µg/mL of particulates. Data represents the mean ± SEM of 2 replicate experiments conducted in triplicate. Significant 
differences were determined by two-way ANOVA with Bonferroni’s post-hoc test. * different vs. all other particulates; everything below dotted 
line is significantly different to control (p < 0.05).
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Similarly, when the particulates were added at 30 µg/mL to the UV-irradiated 
HaCaT cells, no differences were observed between the individual particulate species 
at any time point (Figure 3.8B). However, differences were detected slightly earlier 
from the 8 h time point onwards, for all particulates when compared to untreated 
UV-irradiated control cells at 0 h, indicating a further time-dependent decrease in 
cell viability (p<0.05). 
In the UV-irradiated cells exposed to particulates at 100 µg/mL, ZnCl2 caused a 
significant decrease in cell viability at 4 h, however at later times the differences 
between ZnCl2 and other particulates was less pronounced as the latter exerted their 
cytotoxic effects (Figure 3.8C). Further time-dependent decreases in cell viability 
from the UV-irradiated controls was observed, occurring in all particulates (except 
for ZnCl2) from 8 h onwards (p<0.05). 
 
3.2.4 IL-6 release from HaCaT cells after 24 h exposure to 
particulates 
Cytokine levels were initially investigated via flow cytometry using a Multiplex 
fluorescent bead assay, which can detect the levels of several different cytokines in a 
small sample volume. The particulates did not induce the production and release of 
cytokines in either sham- or UV-irradiated cells (data not shown). Exposure to UV 
radiation alone did result in an increase in IL-6 expression, but due to the quantitative 
limitations of the multiplex assay, this did not reach statistical significance. 
Therefore, in order to accurately quantify IL-6 expression in our test system, a 
specific ELISA for IL-6 was used (as described in section 2.6). While it is not 
possible to measure multiple cytokines in the same sample using an ELISA assay, it 
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does provide a more accurate level of the release of an individual cytokine of 
interest.  
The level of IL-6 expression in sham-irradiated and UV-irradiated cells is seen in 
Figure 3.9. All data is represented as a fold-increase from the sham-irradiated 
control. In sham-irradiated cells, only ZnCl2 at 30 µg/mL induced an increase in the 
levels of IL-6 released from these cells (p<0.05) (Figure 3.9A). For all other 
particulate treatments, levels of IL-6 were observed to be similar to that of the 
untreated control.  
Exposure to UV radiation alone generated a 5-fold increase in IL-6 levels in the 
HaCaT cells (Figure 3.9B). Particulate treatment in UV-irradiated cells was observed 
to attenuate this response at lower doses (1-10 µg/mL), with the further reduction at 
higher doses (30-100 µg/mL) being due to a combination of attenuation and cell 
death. sZnO 30 showed the greatest level of attenuation of all particulate treatments 
at the lowest dose, reducing the 5-fold increase to a 3-fold increase compared to the 
sham-irradiated control. Whilst most particulate treatments did show a slight increase 
in IL-6 levels at the lowest dose of 1 µg/mL, the only particulate that increased IL-6 
levels significantly was ZnCl2. The overall decrease in UV-induced IL-6 release 
from all exposures also appeared to correlate with the decrease in cell viability 
observed in UV-irradiated cells (r2 = 0.5110) (p<0.05), as seen in Figure 3.10. 
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Figure 3.9. Effect of particulates on IL-6 production in sham-irradiated (A) and UV-
irradiated (B) cells. Data is expressed as a fold increase from sham-irradiated control 
cells (19.4 ± 2.2 pg/mL) and represents the mean ± SEM of 3 replicate experiments 
conducted in triplicate. Significant differences were determined by two-way 
ANOVA with Bonferroni’s post-hoc test. * different to all other particulates  
(p < 0.05). 
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Figure 3.10. Correlation of cell viability versus IL-6 release in UV-irradiated HaCaT 
cells exposed to particulates. 
 
3.3 Discussion 
The MTS cell viability assay was used to measure the cytotoxic effect of particulates 
on HaCaT cells. The concentration range of the particulates determined via this assay 
was also useful in determining the dose range to use in further toxicological testing. 
Based on this, it was decided that the 10, 30 and 100 µg/mL doses were the most 
suitable for further testing, as this range covered the whole dose-response curve, 
from a relatively well-tolerated dose (10 µg/mL) to sub-toxic (30 µg/mL) and toxic 
doses (100 µg/mL) to the cells. Furthermore, the cell culture system used in this 
study was designed as a platform in assessing the differences in cytotoxicity and 
cytokine release in a reproducible environment. Moreover, it should be noted that 
whilst this system is not directly reflective of an in vivo exposure system in the sense 
that we are only investigating the effects of NP and/or UV exposure on a single cell 
r
2
=0.5110 
77 
 
type, when in reality multiple cell-cell interactions would be involved, it can still be 
used to form the basis of some of the processes that might be occurring.  
Additionally, the UV dose of 1.26 J/cm2  (1 MED UVB and 0.5 MED UVA) 
represents a physiological exposure that might be received by a person who has been 
in the noonday summer sun for 30 min in Sydney, Australia at 33.86°S latitude 
[137]. If NPs in sunscreens were able to penetrate through the dead layer of 
corneocytes (cornified keratinocytes) that form the stratum corneum, the first cells 
they would interact with are live keratinocytes, thus forming the basis of this study. 
However, studies such as those by Gulson et al. [107] have suggested that the 
amount of zinc from ZnO particulates that can penetrate through the skin as a result 
of sunscreen application is very minimal. For example, they detected that the amount 
of rare stable zinc isotope in the blood after a 5 day application period of around 2.8-
5.8 mg/cm2 of sunscreen per day was only 1/1000th of that which is normally present 
in blood, suggesting that only a very small amount of zinc from the sunscreens 
penetrated through the epidermal layers of the skin. Furthermore, they noted that the 
female participants showed greater levels of absorption than the male participants. 
When they compared the difference between nano and bulk based sunscreens, they 
interestingly found no difference between the two different formulations in men, but 
a significant difference in the female subjects [107].  
Additionally, the exposure levels used in this study are greater than what any human 
systemic exposure would be from sunscreen use (120 – 12,000 times greater). These 
values were calculated (see appendix) based on data generated by Gulson et al. 
[107]. The amount of sunscreen applied to the skin of subjects with highest uptake 
(i.e. females receiving nano ZnO) was an average of 3.8 mg/cm2 over a 35 x 26 cm 
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skin section. This equated to a total dose of 3.5 g of applied sunscreen. As the 
sunscreen content of ZnO was 20% by weight, this equated to a total amount of 
applied ZnO of 0.7 g of ZnO. Additionally, the measured amount of total blood Zn 
tracer from the sunscreen that was found in this group was 15.8 µg (range 8.6 – 30.8 
µg). Using the upper limit of 31 µg, the total blood volume (4.7 L) and the 
proportional weight of Zn in ZnO (80%) provides an estimated systemic blood 
concentration of 8.25 ng/mL. Taking the worst case scenario that live cells (including 
keratinocytes) are exposed to this systemic blood concentration, then the in vitro 
dose range used in this study of 1 – 100 µg/mL of ZnO NPs is 120 to 12,000 fold 
higher. Based on this information, the concentrations used in this in vitro test system 
are at least two orders of magnitude higher than the estimated systemic exposure 
dose from in vivo absorption [107]. 
Whilst that data was based on a few assumptions such as a uniform application, 
intact skin, correct application dose, etc., it is clearly an overestimate and represents 
the worst case scenario. Furthermore, the in vitro test system calculation also 
assumes 100% confluency and uniform distribution of the NPs in the well. 
Therefore, whilst the doses in our study are considered high when comparing to an 
“actual” exposure scenario, they are relevant in observing differences in response to 
the different particulates that would otherwise not have occurred if lower doses were 
used.   
The use of the MTS assay in evaluating the timeline of cytotoxicity to HaCaT cells 
that had been exposed to particulates over a 24 h period proved useful in that it was 
able to determine that at sub-toxic (30 µg/mL) and toxic (100 µg/mL) doses in sham-
irradiated cells, significant amounts of cytotoxicity were occurring within the first  
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12 h. The only exception to this was ZnO Bulk, the largest of the ZnO materials 
tested. At the lowest dose (10 µg/mL), ZnO Bulk was the only particulate that 
showed significant cytotoxicity, however at the highest dose it was proven to be the 
best tolerated. This is in contrast to other studies looking at the effects of ZnO 
particulates in THP-1 cells which found that larger sized ZnO particulates were 
better tolerated across the same dose range over the same period [116].  
Whilst the responses of different cell types to particulates would be expected to be 
different, other cell viability assays would need to be utilised to confirm these 
effects, such as trypan-blue exclusion staining or PI staining. Another valuable 
finding determined from the kinetic-based MTS assay was the effect of UV radiation 
on the cells causing a progressive time-dependent decrease in viability over 24 h, 
suggesting that intervention in the process by additional protective agents in 
sunscreens (e.g. antioxidants) may be possible. Furthermore, results from the assay 
also suggested that co-exposure to UV and particulate treatment was more 
detrimental to the HaCaT cells than UV-radiation alone. However, it again must be 
stressed that the particulate doses used in this study are greater than what we would 
normally be exposed to.  
When comparing the effects of ZnO particulates against TiO2 NPs, it was evident 
that TiO2 particulates were better tolerated, even at very high concentrations. Kroll et 
al. [169] has reported that NPs may interfere with colourimetric assays such as MTT, 
by causing an apparent increase in MTT-formazan light absorption in a concentration 
dependent manner, therefore suggesting that such assays be used with caution. In our 
test system, only one particulate may have generated such an optical interference 
(TiO2). At extremely high concentrations (5 mg/mL), the viability of HaCaT cells 
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treated with both TiO2 anatase and rutile appeared to increase. This was based on the 
fact that the cell free blanks with just TiO2 alone generated increases in absorbance at 
the higher doses (increasing from 0.101 AU in the media alone samples to 0.645 AU 
at the 5 mg/mL), although these control well values were subtracted from the test 
well values to accounts for the direct light absorption of NPs during the MTS 
measurements. In order to help overcome this, we employed methods such as 
centrifuging the plates to limit any chance of aspirating particulate matter that may 
interfere with the absorbance. Whilst using this method did not completely remove 
the chance of aspirating particulate matter, it did remove a lot of the initial 
interference. Furthermore, the procedure of plate spinning agrees with an 
independently developed protocol published in the Quality Handbook: Standard 
Procedures for Nanoparticle Testing published recently by Nanommune for the 7th 
Framework Programme [170].  
In our test system, the only cytokine released in significant amounts was IL-6. This 
cytokine is regarded as a pleiotropic pro-inflammatory cytokine with multiple 
functions, such as mediating T cell proliferation, differentiation (Th1 or Th2) [171], 
survival and inhibition of apoptotic signals [172].   
Furthermore, it has been shown to mediate the acute phase response and induce fever 
[80]. The expression of IL-6 in our study was found to be induced by UV radiation 
alone and not by NP exposure. As discussed earlier, UV-radiation can induce DNA 
damage in the form of CPDs. It is thought that the production of CPDs from DNA 
damage plays a role in initiating the production of immunosuppressive cytokines, 
such as IL-6 [173]. Petit-Frere et al. [173] first showed this in primary keratinocytes, 
observing correlations between IL-6 release, CPD formation and DNA absorption.  
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IL-6 has also been shown to directly activate the signal transducers and activators of 
transcription (STAT) factors, in particular STAT1 and STAT 3 via the Janus Kinases 
(JAK) signalling pathway [174-176]. Interestingly, STAT3 has been linked to skin 
carcinogenesis via the upregulation of anti-apoptotic proteins such as Bcl-2 and as 
such, aids in the survival of DNA-damaged keratinocytes [172, 177]. Additionally, 
increased expression of STAT3 has been identified in BCC and SCC, suggesting that 
it plays an important role in skin carcinogenesis [178].  Furthermore, this stimulation 
in IL-6 in our study was found to be inversely proportional to the decrease in cell 
viability caused by the particulates and UV radiation. However, in sham-irradiated 
cells, particulate exposure in general did not simulate IL-6 production. This suggests 
that the cytotoxicity caused by particulate exposure in sham-irradiated cells is not 
due to the production of pro-inflammatory cytokines, such as IL-6. 
In UV-irradiated cells, the particulate treatments at low doses (1-10 µg/mL) may be 
attenuating the DNA damage response caused by UV radiation. At higher doses (30-
100 µg/mL), this is most likely due to a combination of attenuation and the cytotoxic 
affect that is being caused by co-exposure of cells to NPs and UV. However this 
would need to be further investigated, by determining if lower doses of particulates 
aid in alleviating the DNA damage caused by UV radiation alone, and if this factor 
still attenuates the response of IL-6 generation, as caused by UV radiation alone.  
Lastly, as the high doses of particulates used in this study had no effect on IL-6 
levels in sham-irradiated cells, this suggests that they are unlikely to generate an 
immune modulating response from exposed keratinocytes, although further testing 
using primary keratinocytes and fibroblasts would also need to be done to confirm 
this observation. From this study, we can conclude that the pro-inflammatory 
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cytokine IL-6 is not a contributing factor to, or IL-6 release a consequence of, NP-
induced cytotoxicity in HaCaT cells.  
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Chapter 4 – Mechanisms of 
nanoparticle cytotoxicity in  
HaCaT cells 
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4.1 Introduction 
Zinc (Zn) in an important trace element that is present as a structural component in 
various proteins, which includes growth factors, cytokines, receptors and enzymes 
[179]. It is an essential trace element and is required for both protein function 
(enzymes and transcription factors) and biological activity [180, 181]. Furthermore, 
Zn forms a purely structural role in Zn fingers. Zn fingers are proteins that play a role 
in the replication and transcription process of DNA [182, 183]. It has been estimated 
that 10% of all cellular proteins (including >200 enzymes) may bind Zn [179]. Thus, 
cellular Zn levels are maintained by a tightly controlled homeostatic process 
involving Zn transporters, channels and MTs [179].  
Whilst Zn plays an important role in cellular functions, it is not unusual that 
imbalances in its intracellular levels can cause abnormalities. Wang et al. [184] 
showed that mutations in a particular Zn transporter gene (ZIP4) caused the inherited 
disorder acrodermatitis enteropathica, impairing the ability of the intestine to absorb 
Zn. Hojyo et al. [185] observed that mice with a Zn transporter gene knockout 
(ZIP14), displayed retarded growth and impaired gluconeogenesis. There is also 
evidence that highlights the role of Zn in enhancing wound repair and the 
reepithelialisation process [186]. Moreover, it has been reported in a murine model 
that inflammation may increase as a result of Zn deficiency, whereas its 
supplementation attenuates the response [187].  
Whilst deficiencies in Zn are well documented, toxicity to Zn is also not a new 
phenomenon [188]. Prolonged Zn exposure may also cause copper deficiency, 
despite copper’s higher affinity than Zn to metal binding proteins such as MTs, thus 
excessive Zn can make less copper available in the body [188, 189].  Furthermore, 
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inhalation of industrial fumes containing Zn can also induce metal fume fever, which 
is characterised by fever, chills and impairment of pulmonary function [190].  
In Chapter 3, ZnO particulates were shown to generate cytotoxicity in HaCaT cells. 
However, what remains elusive is the mechanism by which this cytotoxicity is 
occurring. ZnO NP exposure has been shown to induce ROS, which can cause 
oxidative stress, DNA damage and inflammatory reactions, leading to cytotoxicity 
[113, 191, 192]. Recently studies have shown evidence that cytotoxicity to ZnO 
particulates may in part be due to the release of Zn2+ [112, 120, 121, 123, 193]. Thus 
an exact mechanism of cytotoxicity caused by ZnO particulate exposure is not 
known. Shen et al. [112] have hypothesised that intracellular NP dissolution is 
occurring in acidic microenvironments, such as endosomes. Furthermore they 
showed that this resulted in an increase in intracellular Zn2+ levels and that this 
increase was strongly correlated (r2= 0.945) to the cytotoxicity observed in their 
immune cell test system. Sasidharan et al. [121] noticed a similar effect, whereby an 
acidic environment resulted in dissolution of ZnO nanocrystals causing cytotoxicity 
towards breast adenocarcinoma cells. This increase in free Zn2+ in the cytosol is 
thought to have further consequences, such as increase in ROS [120, 193]. Kao et al. 
[193] showed that the addition of ZnO NP treatment to Jurkat cells triggered a 20-
fold increase in cytosolic Zn2+ levels and a 7-fold increase in mitochondrial Zn2+. 
They also showed that the influx of Zn2+ from the cytosol to the mitochondria caused 
changes in the mitochondrial membrane potential, leading to an increase in 
mitochondrial membrane permeability. This increased leakiness of the mitochondrial 
membrane caused release of cytochrome c, triggering the intrinsic apoptotic pathway 
[193]. Buerki-Thurner et al. [120] showed a similar result, however they also found 
that the damage caused to the mitochondria results in an increase in ROS and 
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oxidative stress, which can also induce apoptosis. Numerous other studies have 
shown that NP exposure has resulted in ROS production within cells [112, 113, 120, 
124]. However it is unclear if the generation of ROS is the sole cause of cytotoxicity 
or merely just a consequence. Based on the aforementioned information, this chapter 
will investigate the mechanism of cytotoxicity that occurs when HaCaT cells are 
exposed to NPs.  
As mentioned earlier, Zn2+ that arise from the breakdown of ZnO NP are thought to 
be a contributing factor to NP-induced cytotoxicity. Therefore in this study, an 
investigation was undertaken to see if Zn2+  play a role in the cytotoxic effect elicited 
by ZnO particulates. Intracellular Zn2+ delivered from ZnO NPs was investigated 
utilising the zinc-specific fluorescent indicator, zinquin, delivered to the cell in its 
ethyl ester form [112, 120]. 
Common methods for measuring intracellular ROS production involves two 
distinctly different probes, i.e. DCF-DA and MitoSOX™ Red [112, 194-196]. DCF-
DA is a non-polar molecule that can penetrate cell membranes, where intracellular 
esterases cleave the diacetate groups. This creates a newly polar molecule that is 
incapable of moving outside the cell. The new molecule 2’,7’-
dichlorodihydrofluorescein becomes fluorescent when it is oxidised via interaction 
with peroxides. Using a flow cytometer, quantification of intracellular ROS levels 
can be determined. As aforementioned, another probe that is utilised to detect ROS is 
MitoSOX™ Red. This probe is effective in measuring mitochondrial superoxide 
production via flow cytometry and works in a similar fashion to that of DCF-DA. 
Therefore, ROS production was assessed in this test system using both of these 
probes in cells exposed to particulates and/or UV radiation.  
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In Chapter 3 it was shown that NP at high doses was cytotoxic in HaCaT cells.  
However, it is also important to determine the cell death pathways that are involved 
following exposure to these ZnO particulates. In order to understand the mechanisms 
that are occurring, in depth research into cell death pathways is needed. Whilst new 
modes of cell death have been described, this study will only focus on apoptosis and 
necrosis [197].  
Apoptosis, commonly known as “programmed cell death” is the orderly process by 
which a cell essentially commits suicide. The cells undergo characteristic 
morphological changes, which involves cell shrinkage and breakdown of organelles 
[198]. Another important component of this pathway is that the cells form apoptotic 
bodies that are instantly recognized and phagocytosed by surrounding macrophages 
and phagocytic cells, and are thus removed [199]. In stark contrast to this process is 
necrosis, usually occurring after an ‘insult’ to the cell such as trauma or ischemia 
[199]. When cells undergo necrosis, they usually swell and burst releasing their 
intracellular contents and thus elicit an inflammatory response [197].  
Determining the pathways involved in cell death is important in in vitro toxicological 
studies, as it provides a greater understanding of the potential mechanisms that may 
be occurring. A common method for examining apoptotic and necrotic cell death in 
cell cultures is via flow cytometry. Under normal circumstances, one of the lipid 
components of the plasma membrane, PS is located on the inner portion of the cell 
membrane [200]. When a cell is to undergo apoptosis, the PS flips to the outside due 
to the action of floppase (an enzyme which causes transbilayer translocation of 
phospholipids away from the cytosol) and is unable to flip back due to a lack of ATP 
and the inactivation of flippase (an ATP dependent enzyme that causes cytosol-
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directed transbilayer movement of phospholipids) [200]. This appearance of PS on 
the surface of apoptotic cells signals the surrounding adjacent cells to phagocytose 
them [200]. It should be noted that the appearance of phosphatidylserine on the 
surface of cells also occurs in cells undergoing necrosis and is not an event limited to 
apoptosis [201].  
Nonetheless, it is the early appearance of PS that forms one half of the features that 
are exploited when determining if a cell is undergoing apoptosis via flow cytometry. 
Annexin V, is a protein that preferentially binds to PS and when it is conjugated with 
FITC, a green fluorescent probe, it provides a convenient way to stain apoptotic cells 
when used in combination with propidium iodide (a red fluorescent dye that is 
excluded from cells with intact membranes). Thus individual cells can be 
distinguished based on their viability and what cell death pathway is being activated, 
i.e.: viable cells will be negative for both PI and Annexin V; apoptotic cells will be 
positive for Annexin V, but negative for PI; late apoptotic and necrotic cells will be 
positive for both PI and Annexin V. This assay was used to determine the cell death 
mechanism of HaCaT cells exposed to the different Zn particulates and/or UV-
radiation. 
This chapter investigates the possible mechanisms of HaCaT cell death by measuring 
intracellular Zn2+ and ROS production and the cell death pathways after 24 h of 
exposure to particulates at 10, 30 and 100 µg/mL and/or UV irradiation. 
Furthermore, this chapter aims to determine if there is a possible link between these 
events in generating the cytotoxicity observed in HaCaT cells. 
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4.2 Results  
4.2.1 Effect of particulate exposure on intracellular Zn2+ levels 
HaCaT cells were exposed to ZnO particulates at 10, 30 or 100 µg/mL and/or UV 
radiation. The intracellular Zn2+ levels were assessed after 24 h of exposure by flow 
cytometry, as described in section 2.8. Figure 4.1 shows that increasing 
concentrations of particulates results in elevated intracellular Zn2+ levels compared to 
that of untreated controls. This is solely attributed to the zinc-based materials and is 
not a general NP-effect, as CeO NPs were also assessed at 100 µg/mL as a Zn-free 
control, and had no significant effect on intracellular Zn2+ levels. 
In sham-irradiated cells, the concentration of particulates that generated a significant 
increase in intracellular Zn2+ was ≥30 µg/mL (p<0.05) (Figure 4.1A). The only 
significant differences seen between treatments in the levels of intracellular Zn2+ 
were between ZnCl2 vs Z-Cote, and ZnCl2 vs ZnO Bulk at 100 µg/mL (p<0.05), due 
mainly to ZnCl2 causing the highest Zn2+ levels, whilst the others had the lowest 
treatment-related levels (Figure 4.1A). Although all particulates were equally potent 
in generating an increase in intracellular Zn2+ in sham-irradiated cells, this was not 
the case in the UV-irradiated cells, where ZnO Bulk was the only particulate that did 
not increase intracellular Zn2+ levels at concentrations ≥30 µg/mL (Figure 4.1B). 
Furthermore, the only difference seen in intracellular Zn2+ levels for UV-irradiated 
cells was between ZnO 30 and ZnO Bulk at 30 µg/mL (p<0.05), due to the smaller 
variability in the response to these treatments (Figure 4.1B).  
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Figure 4.1. Levels of intracellular Zn2+ release in HaCaT cells following ZnO 
particulate exposure in sham-irradiated (A) and UV-irradiated cells (B). Data is 
expressed as a fold-increase from sham-irradiated control cells (1.65 ± 0.08 relative 
fluorescence units x 103), and represents the mean ± SEM of 3 independent 
experiments conducted in triplicate. Statistical significance determined by two-way 
ANOVA with Bonferroni’s post-hoc test. *different to all other particulates; 
everything above the dotted line is significantly different to control (p < 0.05). 
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In both sham- and UV-irradiated cells following Zn-based treatments, there appeared 
to be a dose-dependent increase in the levels of intracellular Zn2+. Therefore, the 
levels of intracellular Zn2+ shown in Figure 4.1A & B were correlated (linear 
regression analysis) against the cell viability % determined via MTS, shown in 
Figure 3.5A & B. The graphs of these correlations and the calculated r2 values are 
shown below in Figures 4.2 and 4.3 and Table 4.1, respectively.  
In comparing the different Zn-based treatments, each generated a significant 
correlation between intracellular Zn2+ levels and cell viability, except for the ZnO 
Bulk and UV co-exposure (Figure 4.3), which did not show a significant correlation 
(r2=0.0702). Altogether, this suggests that the elevation in intracellular Zn2+ from 
particulate exposure may play a role in the cytotoxicity observed in the test system. 
However, this would need to be further investigated in primary keratinocytes and 
fibroblasts to confirm if this correlation also holds for those cell types. 
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Figure 4.2. Correlations of cell viability (%) vs intracellular Zn2+ ion levels in sham-irradiated HaCaT cells.
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Figure 4.3. Correlations of cell viability vs intracellular Zn2+ ion levels in UV-irradiated HaCaT cells.
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Table 4.1. List of r2 and p values describing the correlations between cytotoxicity and 
intracellular Zn2+ levels in exposed HaCaT cells. Data is derived from the graphs 
shown in Figures 4.2 and 4.3. 
 
4.2.2 Intracellular ROS peroxide production in HaCaT cells  
HaCaT cells were treated with the ZnO and TiO2 particulates at 10, 30 and 100 
µg/mL and/or UV radiation, immediately after being dosed with DCF-DA (as 
described in section 2.9.2). The amount of intracellular peroxide generated in the 
cells was assessed 24 h later by flow cytometry. To confirm the sensitivity of the 
assay, exogenous H2O2 (0.1% v/v final concentration) was added to the cells and 
used as a positive control. H2O2 produced a 2.1 ± 0.2 fold increase on the basal 
peroxide levels in sham-irradiated cells (i.e. basal = 2200 ± 650 relative fluorescence 
units), and a 5.4 ± 0.3 fold increase in UV-irradiated cells, while UV itself only 
doubled the basal peroxide production.  
 
Particulate r2 Value Significance 
ZnO 30 0.7696 <0.05 
ZnO 30 + UV 0.4632 <0.05 
sZnO 30 0.6603 <0.05 
sZnO 30 + UV 0.7658 <0.05 
Z-Cote 0.8806 <0.05 
Z-Cote + UV 0.4363 0.05 
ZnO Bulk 0.3866 0.05 
ZnO Bulk + UV 0.0702 0.43 
ZnCl2 0.8655 <0.05 
ZnCl2 + UV 0.8207 <0.05 
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In sham-irradiated cells, ZnO Bulk was the only particulate that generated a 
significant increase in the level of intracellular peroxides (p<0.05 for 10-100 µg/mL), 
and was also significantly higher than the other particulates at all concentrations 
tested, as shown in Figure 4.4A (p<0.05).  
When the cells were exposed to UV radiation, only sZnO 30 exposure generated 
significantly more peroxides (i.e. 6-fold sham-irradiated cells), however this effect 
only occurred at the intermediate dose of 30 µg/mL (Figure 4.4B; p<0.05).  
In order to determine if there was a link between the generation of peroxides and the 
decrease in cell viability observed in this test system from particulate exposure, 
correlation (linear regression analysis) graphs were established. That is, the % cell 
viability of HaCaT cells exposed to ZnO particulates determined via MTS (shown in 
Figure 3.5A & B) was plotted against the fold increases in intracellular peroxide 
shown in Figure 4.4. The graphs of these correlations and the calculated r2 values 
seen are shown below in Figures 4.5 and 4.6 and Table 4.2, respectively. 
All particulate treatments showed no significant correlation between intracellular 
peroxide production and the observed decrease in cell viability, except for the sham-
irradiated cells exposed to ZnO Bulk particulate (Figure 4.5). 
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Figure 4.4. Effect of particulates on the generation of intracellular ROS (measured as 
peroxides) in HaCaT cells. ROS levels were measured in sham-irradiated (A) and 
UV-irradiated cells (B). Data is expressed as a fold-increase from sham-irradiated 
control cells (2.20 ± 0.65 relative fluorescence units x 103), and represents the mean 
± SEM of 3 independent experiments conducted in triplicate. Significant differences 
were determined by two-way ANOVA with Bonferroni’s post-hoc test. * different to 
all other particulates, (p < 0.05). 
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Figure 4.5. Correlations of % cell viability vs intracellular peroxide generation in sham-irradiated HaCaT cells. 
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Figure 4.6. Correlations of % cell viability vs intracellular peroxide generation in UV-irradiated HaCaT cells.
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Table 4.2. List of r2 and p values describing the significance of respective 
correlations for peroxide production vs cell viability. Data is derived from the graphs 
shown in Figures 4.5 and 4.6. 
Particulate r2 Value Significance 
ZnO 30 0.2330 0.16 
ZnO 30 + UV 0.0461 0.60 
sZnO 30 0.0474 0.57 
sZnO 30 + UV 0.4706 0.06 
Z-Cote 0.0242 0.71 
Z-Cote + UV 0.2741 0.70 
ZnO Bulk 0.6321 <0.05 
ZnO Bulk + UV 0.0036 0.85 
ZnCl2 0.0593 0.45 
ZnCl2 + UV 0.3773 0.11 
 
4.2.3 Mitochondrial superoxide production in HaCaT cells  
HaCaT cells were treated with ZnO and TiO2 particulates at three different 
concentrations (10, 30, 100 µg/mL) immediately after being loaded with MitoSOX 
Red (see section 2.9.1). The relative fluorescence was measured after 24 h of 
exposure via flow cytometry, from which the results are shown in Figure 4.7. 
In sham-irradiated HaCaT cells, all ZnO particulate treatments at 100 µg/mL induced 
a dose-dependent increase (~4.8-fold of control) in mitochondrial superoxide 
generation (Figure 4.7A). The titania particles showed a slight increase in superoxide 
generation from control (1.4- and 1.7-fold for anatase and rutile, respectively), 
however this did not reach statistical significance. Similarly, all ZnO particulate 
treatments at 30 µg/mL caused a modest increase in superoxide (between 3- to 4-
fold), but these effects did not reach statistical significance due to the biological 
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variability in responses. When comparing the effects elicited between the 
particulates, the only statistically significant differences were observed between ZnO 
Bulk (with the highest superoxide level of the ZnO particles) and the two titania 
particulates at 100 µg/mL (p<0.05).  
In UV-irradiated HaCaT cells (Figure 4.7B), there was a 70% increase in 
mitochondrial superoxide production due to UV radiation alone. All ZnO particulates 
at 100 µg/mL, except for sZnO 30, elicited a dose-dependent increase in superoxide 
production (~4.3 fold of sham-irradiated controls). The titania particulates again 
generated a slight increase in superoxide production from the UV-irradiated control 
cells, but this was not statistically significant. 
In both sham- and UV-irradiated cells following Zn-based treatments, there appeared 
to be a dose-dependent increase in mitochondrial superoxide production. Therefore, 
the levels of mitochondrial superoxide production shown in Figure 4.7A & B were 
correlated against the cell viability determined via MTS, shown in Figure 3.5A & B. 
The graphs of these correlations and the calculated r2 values are shown in Figures 4.8 
and 4.9 and Table 4.3, respectively.  
In comparing the different Zn-based treatments, each generated a significant 
correlation between mitochondrial superoxide production and cell viability. This 
strongly suggests that mitochondrial superoxide production from ZnO particulate 
exposure may play a role in the cytotoxicity observed in the test system. However, 
this would need to be further investigated in primary keratinocytes and fibroblasts to 
confirm if this correlation also holds for those cell types. 
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Figure 4.7. Effect of particulates in generating mitochondrial superoxide in HaCaT 
cells. Mitochondrial superoxide levels were measured in sham-irradiated (A) and 
UVAB-irradiated cells (B). Data is expressed as a fold-increase from sham-irradiated 
control cells (14.6 ± 2.0 relative fluorescence units x 103), and represents the mean ± 
SEM of 2-3 independent experiments conducted in triplicate. Significant differences 
were determined by two-way ANOVA with Bonferroni’s post-hoc test;  
everything above the dotted line is different to control (p < 0.05). 
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Figure 4.8. Correlations of % cell viability vs mitochondrial superoxide generation in sham-irradiated HaCaT cells. 
0 50 100
0
2
4
6
8
10
Correlation of ZnCl2
% Cell viability
M
i
t
o
c
h
o
n
d
r
i
a
l
 
S
u
p
e
r
o
x
i
d
e
103 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Correlations of % cell viability vs mitochondrial superoxide generation in UV-irradiated HaCaT cells
104 
 
Table 4.3. List of r2 and p values describing the significance of respective correlaions 
for superoxide production vs cell viability. Data is derived from the graphs shown in 
Figures 4.8 and 4.9. 
Particulate r2 Value Significance 
ZnO 30 0.4921 <0.05 
ZnO 30 + UV 0.6129 <0.05 
sZnO 30 0.4738 <0.05 
sZnO 30 + UV 0.3882 <0.05 
Z-Cote 0.7372 <0.05 
Z-Cote + UV 0.7893 <0.05 
ZnO Bulk 0.6080 <0.05 
ZnO Bulk + UV 0.6167 <0.05 
ZnCl2 0.6381 <0.05 
ZnCl2 + UV 0.3639 <0.05 
 
4.2.4 Determination of cell death pathway in HaCaT cells exposed to 
particulates  
Cell death pathways of apoptosis and necrosis were determined via the Annexin V-
FITC staining technique (as described in section 2.10). Figure 4.10 below is a 2-
dimensional representation of the fluorescence intensity of the two probes, PI (y axis) 
and FITC (x axis) in a UV-irradiated control sample. For data analysis, these plots 
were divided into four quadrants: the bottom left quadrant (Q3) represented the 
viable cell population that was negative for both PI and FITC; the bottom right 
quadrant (Q4) represented the apoptotic cell population that was positive for FITC 
but negative for PI; and the top right quadrant (Q2) represented the late 
apoptotic/necrotic cell population that were positive for both PI and FITC; while the 
top left quadrant (Q1) was not counted as part of the analysis, as this represented 
cellular debris and was only positive for PI.  
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The percentage of events falling into the each of the respective quadrants was used to 
determine the proportion of viable, apoptotic and necrotic cells. HaCaT cells exposed 
to ZnO particulates and/or UV radiation were measured after 24 h of exposure for the 
extent of either apoptotic or necrotic cell death via flow cytometry. TiO2 was not 
investigated as it did not generate the degree of cytotoxicity that was caused by the 
ZnO particulates at the main dose range chosen (i.e. 0-100 µg/mL; Figure 3.5A & B).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. Identification of HaCaT cell subpopulations in flow cytometry data 
plots; this 2-dimensional representation shows the fluorescence intensity for PI and 
Annexin V-FITC stained cells, 24 h post UV-irradiation. 
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When sham-irradiated cells were treated with particulates at 10 µg/mL, no 
differences were observed in the apoptotic cell populations between any of the 
treatments (Figure 4.11). Differences were observed in the viable and necrotic cell 
population, with the two larger particulates (Z-Cote and ZnO Bulk) generating more 
necrosis (25% and 15%, respectively) than any other treatment (p<0.05).  
In the sham-irradiated cells treated with particulates at 30 µg/mL, no differences 
were observed in the apoptotic cell populations irrespective of the different 
particulate treatments (Figure 4.11). In contrast, significant differences were seen 
between control cells and sZnO 30 treated cells, with its higher viable cell 
population, which were also different to ZnCl2, ZnO 30 and ZnO Bulk (p<0.05). 
However, sZnO 30 treated cells were more viable when compared to Z-Cote treated 
cells, but this did not reach statistical significance. Additionally, differences were 
observed between Zn-based treatments in the necrotic cell population, with ZnCl2, 
causing significantly more necrosis than ZnO 30, sZnO 30 and ZnO Bulk (p<0.05).  
In the sham-irradiated cells at the highest concentration (100 µg/mL), no differences 
were observed between any of the particulate treatments in the uniformly low viable 
cell populations. Differences were only observed in the apoptotic and necrotic cell 
populations between particulate treatments, however this was only between the 
lowest value seen with sZnO 30 exposure and highest value from ZnO Bulk 
treatment (Figure 4.11) (p<0.05).  
In the UV-irradiated HaCaT cells, UV-alone caused ~50% of the cells to undergo 
apoptosis (Figure 4.12). When the UV-irradiated cells were treated with  
10 µg/mL of particulates, the number of cells that remained viable or dying via 
apoptosis or necrosis were similar between the different particulate treatments 
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(Figure 4.12). At this same concentration, all Zn-based treatments induced significant 
amounts of necrosis above that seen in UV-irradiated controls.  
In the UV-irradiated cells treated with 30 µg/mL of particulates, the levels of 
apoptosis were similar between treatments, except for sZnO 30, which had a higher 
level but this was still less than that seen in the UV-irradiated control cells (p<0.05) 
(Figure 4.12). At this same concentration, all particulate treatments induced 
significant amounts of necrosis when compared to UV-irradiated controls. 
Furthermore, the only differences observed in the number of cells dying via necrosis 
due to particulate treatment was between the lower amount seen with sZnO 30 and 
all other particulates (p<0.05). 
At the cytotoxic dose of 100 µg/mL in the UV-irradiated cells, there were no 
significant differences observed between any of the particulate treatments across the 
three cell populations (Figure 4.12). Additionally, all particulate treatments were 
found to cause significantly more necrosis compared to UV-irradiated controls alone 
(p<0.05).  
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Figure 4.11. Effect of particulate treatment on the population of viable, apoptotic and necrotic cells after 24 h in sham-irradiated cells. 
Data represents the mean ± SEM of 2 independent experiments conducted in triplicate.Significant differences were determined by two-
way ANOVA with Bonferroni’s post-hoc test. *different to all other treatments within the same population, # different to control 
population, $ different to ZnCl2 (p < 0.05). 
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Figure 4.12. Effect of particulate treatment on the population of viable, apoptotic and necrotic cells after 24 h in UV-irradiated cells. 
Data represents the mean ± SEM of 2 independent experiments conducted in triplicate. Significant differences were determined by two-
way ANOVA with Bonferroni’s post-hoc test. *different to all other treatments within the same population, # different to control 
population (p < 0.05). 
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Another useful measure from PI staining of cells is an independent determination of 
cell viability. Therefore, cell viability obtained using the MTS assay (Figure 3.5A & 
B) was compared to that determined using PI staining by flow cytometry. Figures 
4.13 and 4.14 show the correlations of the cell viability generated via MTS plotted 
against the cell viability generated from PI staining, in both sham- and UV-irradiated 
cells. For all particulate treatments in both sham- and UV-irradiated cells, strong 
correlations were observed and are summarised in Table 4.4-4.5. Most of these 
correlations were significant (p<0.05), with only the sham-irradiated ZnO Bulk and 
UV-irradiated ZnCl2 not showing a significant correlation between the cell viability 
determined via PI staining and the MTS assay. Overall, this suggests that both the 
MTS and PI staining techniques are suitable measures of cell viability in our test 
system. 
. 
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Figure 4.13. Correlations of cell viability generated via MTS vs cell viability generated via PI staining in sham-irradiated HaCaT cells. 
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Figure 4.14. Correlations of cell viability generated via MTS vs cell viability generated via PI staining in UV-irradiated HaCaT cells.
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Table 4.4 Comparison of the MTS assay and PI-staining in determining the % cell 
viability of sham-irradiated HaCaT cells treated with Zn particulates. Data is derived 
from the graphs shown in Figures 4.13. 
 
Table 4.5 Comparison of the MTS assay and PI-staining in determining the % cell 
viability of UV-irradiated HaCaT cells treated with Zn particulates. Data is derived 
from the graphs shown in Figures 4.14. 
 
 
 % Cell Viability  Correlation (MTS vs PI) 
Particulate Dose (µg/mL) MTS PI r2 
ZnO 30 10 104.5 96.3 0.9864 
30 57.2 42.7 
100 4.4 6.7 
sZnO 30 10 89.8 95.6 0.9582 
30 17.6 50.9 
100 0.7 6.5 
Z-Cote 10 63.2 70.7 0.9510 
30 54.8 33.9 
100 3.5 6.8 
ZnO Bulk 10 34.7 66.8 0.8157 
30 49.0 36.1 
100 27.7 9.0 
ZnCl2 
 
10 94.4 96.5 0.9135 
 30 50.4 24.2 
100 1.1 5.6 
 % Cell Viability  Correlation (MTS vs PI) 
Particulate Dose (µg/mL) MTS PI r2 
ZnO 30 10 40.2 47.1 0.9913 
30 13.2 19.9 
100 0.50 12.7 
sZnO 30 10 41.2 49.5 0.9840 
30 6.6 27.5 
100 2.0 20.2 
Z-Cote 10 28.0 31.4 0.9912 
30 13.6 25.7 
100 4.0 16.9 
ZnO Bulk 10 20.8 28.5 0.9928 
30 10.2 22.9 
100 2.5 12.5 
ZnCl2 
 
10 21.7 47.7 0.8652 
 30 6.1 19.0 
100 1.1 5.6 
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4.3 Discussion 
A proposed paradigm of ZnO particulate-induced cytotoxicity is that they are taken 
up by the cells, dissolve into bioavailable Zn2+ and exert their toxicity via this route. 
Based on the in vitro investigation undertaken in this chapter, the following 
mechanistic pathway of ZnO particulate-induced cytotoxicity is proposed. 
Firstly, when the cell is exposed to ZnO particulates, they are endocytosed by the 
cell. This results in the particulates accumulating in the endosomes. Due to the highly 
acidic nature of endosomes (pH ~5.5), the particles dissolve and are eventually 
released into the cell, thus generating an increase in cytosolic Zn2+ levels, which may 
then induce cell death via necrosis [193, 202]. It is unlikely that extracellular 
dissolution of Zn2+ causes cytotoxicity, as dialysates generated from ZnO 30 NPs 
were not cytotoxic to human THP-1 monocytes [112]. Also, it has been shown that 
when soluble Zn was added to cell culture media, it rapidly forms a poorly soluble, 
amorphous zinc-carbonate-phosphate nano-sized precipitate [203]. As we were 
observing cytotoxicity in this study, it can be assumed that the dissolution of 
particulates is most likely to be occurring intracellularly. This dissolution mechanism 
of cytotoxicity may explain why TiO2 NPs were not cytotoxic in HaCaT cells. Whilst 
it would be expected that the mechanism of uptake into the cells would differ 
between two different materials, the cytotoxic mechanism once inside cells is most 
likely to be attributed to the differences in solubility, with TiO2 NPs being practically 
insoluble and therefore more stable in acidic pH environments of endosomes [204]. 
As a result, it is not unusual that increasing concentrations of particulates 
corresponded with an increase in the amount of intracellular Zn2+ in these cells 
(Figure 4.1A). Surprisingly, an effect due to particle size was not observed, as all 
particulates generated a similar cytotoxicity profile, suggesting that the mechanisms 
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of uptake at least for Zn-based particulates may be similar in our test system. 
However, this contradicts other studies showing a size-dependent effect in other cell 
types, and may indicate a cell type-specific phenomenon that would need further 
investigation [112, 205]. Conversely, if the mechanism of uptake of the different-
sized ZnO particulates was similar, along with the dissolution rates after the exposure 
period, then we would have expected the cytotoxicity profiles of all the ZnO 
particulates to also be similar.  
Inverse correlations between raised intracellular Zn2+ levels versus cell viability for 
the particulate treatments suggest that there may be a potential link, with all 
particulates tested showing a significant correlation (Figure 4.2), except for cells 
treated with ZnO Bulk and UV-irradiation. Whilst this suggests a potential link, it is 
not sufficient to suggest that the cytotoxicity detected in our test system is solely 
attributed to, or caused by, Zn2+-induced toxicity without further investigation. 
In the cell under normal physiological conditions, the level of intracellular Zn2+ is 
highly regulated [124, 193]. This process usually involves metal binding proteins 
such as metallothioneins (MTs) and zinc transporters, as well as Zn2+ sequestration 
by the mitochondria [125]. Mitochondria themselves appear to have a high Zn2+ 
content, but inhibition of mitochondrial uptake causes an increase in cytosolic Zn2+ 
levels [128]. An overload of Zn2+ in the mitochondria can cause depolarisation of the 
mitochondrial membrane potential, thus effecting its permeability [124, 193, 206]. 
Dineley et al. [207] observed that loss of mitochondrial membrane permeability, as 
well as the generation of ROS by mitochondria, could be induced by increased 
intracellular Zn2+ levels. Mitochondrial dysfunction and elevated ROS levels 
eventually lead to the death of the cell [208]. What is not known is whether this 
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mechanism of cell death is due to: (a) intracellular Zn2+ alone; (b) the generation of 
ROS; or (c) a combination of both.  
Measurement of ROS in the form of peroxides, using the DCF-DA assay, has been 
used in numerous studies [112, 196, 209-211]. In the experiments undertaken in this 
study on HaCaT cells, we observed that for most of the particulate treatments, no 
increase in peroxide generation was detected. Only ZnO Bulk particulate in sham-
irradiated cells, and sZnO 30 NPs in the presence of UV irradiation, caused an 
increase in peroxide levels in HaCaT cells. Furthermore, in the sham-irradiated cells, 
the level of peroxide generated from particulate exposure was inversely proportional 
to the doses used. Whilst UV radiation induced a slight increase in peroxide 
generation, the addition of particulates did not further enhance this effect. A reason 
for the lower levels of peroxides generated at higher concentrations of particulates 
might be explained by the fact that cell viability at such high concentrations is low. 
Buerki-Thurnherr et al. [120] recently detected a very slight, but not significant, 
increase in ROS generation after exposure of Jurkat cells to ZnO NPs, which was in 
agreement to the results obtained in this study. 
The results from the MitoSOX Red assay showed that there was a dose-dependent 
increase in mitochondrial superoxide production in both sham- and UV-irradiated 
HaCaT cells treated with the various ZnO particulates. Conversely, the titania 
particulates did not generate similar levels of superoxide. However these results do 
support similar reports of a 3-fold increase from control in UVA-irradiated human-
derived retinal pigment epithelial cells treated with titania particulates [195], as 
compared to the 2.6-fold increase seen in UV-irradiated HaCaT cells in this study.  
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In terms of correlating the ROS generation response to cell viability, significant 
correlations were detected for superoxide production, but not for peroxides. However 
it is difficult to ascertain whether the increases in ROS observed are the cause of 
cytotoxicity to the cells, or merely a consequence of mitochondrial membrane 
disruption that would result in cell death. Shen et al. [112] investigated if ROS 
generation was a contributing factor to ZnO NP-induced cytotoxicity by adding two 
different antioxidant vitamins (E and C) to THP-1 cells. They found that whilst the 
two different antioxidants caused a decrease in ROS generation, they did not alter the 
level of NP-induced cytotoxicity. This suggests that ROS generation is not a sole 
cause of cytotoxicity, but a consequence of such. However this effect of antioxidants 
mitigating the ROS response would need to be investigated in our test system to see 
we observe a similar result. 
Based on the results obtained in these studies, the following hypothesis of 
cytotoxicity in HaCaT cells has been postulated (and is summarised in Figure 4.15): 
When the cells are exposed to ZnO NPs, the particulates are endocytosed and taken 
up into endosomes, whereby the acidic environment causes dissolution of the NPs, 
thus increasing the intracellular Zn2+ levels. In order to maintain homeostatic Zn 
levels, the free Zn2+ ions either bind to MTs or are sequestered into the mitochondria. 
Mitochondrial overload of Zn2+ causes organelle dysfunction and induces ROS 
production, both of which can cause cell death. Interestingly, binding of Zn2+ to MTs 
is sensitive to changes in cellular redox state, in which oxidants have been shown to 
promote release of Zn2+ ions from these proteins. Therefore, the production of ROS 
from mitochondria can induce a positive feedback loop, whereby Zn2+ is released 
from MTs, causing an increase in intracellular Zn2+, which is sequestered into the 
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mitochondria. This process will eventually lead to the death of the cell, most likely 
via necrosis. 
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Figure 4.15. Proposed mechanism of ZnO particulate-induced cytotoxicity in HaCaT cells.
ROS causes 
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In order to determine which of the two main modes of cell death were activated, 
these pathways were assessed via the Annexin-V/PI assay. Whilst the cell death 
pathway of HaCaT cells exposed to ZnO particulates has not extensively been 
investigated, a number of studies on the effect of gold, silicon dioxide and silver NPs 
on the same cells have been examined [111, 212-214]. Interestingly, these studies 
have suggested that these NPs induce HaCaT cells to die via apoptosis. This differs 
to what we observed in our study, where the cells died primarily via necrosis. This 
may be due to the fact that measuring cell death after 24 h of exposure to NPs is too 
late to measure apoptosis, thus explaining why we largely observed necrosis. 
However, Hastings (2012) also observed that HaCaT cell exposure to silver NPs 
caused almost no apoptosis (<5%) when measured over a 24 h period [215]. Other 
studies that measured apoptosis in HaCaT cells detected this at 6 h of exposure with 
Au  particulates [212], and 24 h of exposure with SiO2 [212] and Ag particulates 
[213, 214]. Wilhelmi et al. [129] observed that when mouse RAW 264.7 
macrophages were exposed to ZnO, more necrosis than apoptosis was detected after 
24 h. However other studies of ZnO NP exposure have observed that apoptosis is the 
preferred mechanism of cell death [116, 120, 193]. It should be noted that not all 
studies used the same methods to measure cell death pathways, therefore this can 
make it difficult to make direct comparisons between other studies.  
As other studies have indicated that apoptosis in HaCaT cells can occur as early as 
12 h of exposure to NPs, measuring earlier time-points (time course of cell death 
pathways over 24 h) would prove more useful, however due to time constraints, this 
could not be utilised in this study. 
Another reason for the contrast in results, might be explained by the fact that HaCaT 
cells possess a dysfunctional p53 gene [216]. p53 is an important tumour suppressor 
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gene and plays a role in regulating apoptosis. This feature was first elucidated by 
Yonish-Rouach et al. [217] who observed that re-introducing p53 into a p53-
deficient cell line (i.e. myeloid leukaemic cells that are temperature sensitive) via 
electroporation induced apoptosis due to changes in temperature. Studies in 
thymocytes from p53-knockout mice further showed that p53 was required for 
radiation-induced apoptosis [218, 219]. Whilst HaCaT cells contain a dysfunctional 
p53 gene, they were still able to undergo apoptosis in our test system following 
exposure to UV-irradiation. This suggests the possible activation of a p53-
independent pathway in HaCaT cells. This is supported by studies showing that in 
HaCaT cells, UVB radiation can activate the Fas death receptor (responsible for 
activating the extrinsic pathway of apoptosis) in the absence of a ligand, suggesting 
that UVB alone, can generate apoptosis independent of p53 [220].  
However, whilst the assay used in this study is common and well-validated, further 
investigations would need to be undertaken. One of these include the use of Terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL staining) and 
visually determining if a cell is undergoing apoptosis or necrosis via morphological 
detection using a microscope. Another is by evaluating the presence of different 
executioner caspases, such as caspase-3, 6 and 7, which are all involved in the 
intrinsic and extrinsic pathways of apoptosis, via either antibody staining or western 
blotting [221]. Additionally, measuring cytochrome c release from the mitochondria 
could also be an indicator of the intrinsic apoptotic pathway [222, 223]. All of the 
aforementioned biomarkers are suitable for evaluating apoptosis and could be used to 
confirm whether or not ZnO NP exposure in HaCaT cells induces apoptosis. 
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Chapter 5 – Conclusions and Future 
Directions 
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5.1 Conclusions 
This thesis investigated the toxicological effects of ZnO and TiO2 particulates in 
HaCaT cells. It was established that by using the concentration range  
(1-100 µg/mL) in this study, ZnO particulates were significantly more cytotoxic to 
HaCaT cells than titania particulates. This cytotoxic effect was found to be both 
dose- and time-dependent, generally occurring within 8 h of exposure. Interestingly, 
TiO2 particulates were still less cytotoxic than ZnO particulates even at extremely 
high doses (5000 mg/mL). This highlights that particle material type plays just as 
much of an important role in NP-induced cytotoxicity than does particle size alone.  
As the ZnO NPs are endocytosed by the cell, it is highly likely that they may undergo 
intracellular dissolution in endosomes. This will ultimately increase intracellular 
Zn2+ levels, which may have downstream effects such as causing mitochondrial 
dysfunction and also an increase in ROS, ultimately resulting in cell death. This 
study therefore supports the proposed paradigm of particulate cytotoxicity from 
dissolved ZnO, based on the inverse correlation of raised intracelullar Zn2+ levels 
with cell viability. Additionally, mitochondrial superoxide production in ZnO-
exposed cells further correlated with the observed decrease in cell viability.   
Furthermore, UV radiation was found to elevate IL-6 expression in untreated 
controls. However, exposure of particulates to the cells did not augment this 
response. In fact, exposure to ZnO particulates at sub-cytotoxic doses attenuated the 
cytokine response caused by UV radiation at low doses. As UV radiation causes 
DNA damage in the form of CPDs [43, 55], and that this event alone may play a role 
in the production of immunomodulatory cytokines such as IL-6 [173, 174, 216], it is 
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possible that particulate exposure at low doses may be protecting the cells from UV-
induced DNA damage, however this would need to be further investigated.  
ZnO exposure in HaCaT cells was shown to induce mitochondrial superoxide 
production in a dose-dependent manner, however peroxide production remained 
relatively unchanged. Conversely, titania particulates had no overall effect on 
superoxide or peroxide production in these cells suggesting that the cytotoxicity 
caused by ZnO NP exposure in HaCaT cells is related to superoxide production and 
is Zn dependent.  
The cell death pathway activated in HaCaT cells exposed to ZnO particulates for 24 
h was mainly necrosis and not apoptosis. However, as this is a relatively late time-
point after exposure, the apoptotic signal may have been mostly missed [212-214]. 
Therefore, the extent of apoptosis at earlier time-points involving a time course over 
24 h, would need to be investigated. However, due to time constraints, this aspect 
could not be further investigated in this study.  
Overall, this study was able to show the hazard potential of ZnO and TiO2 
particulates to HaCaT cells (a human keratinocyte cell line). It should be noted 
however that the doses used in this study were higher (15 – 15,000 fold) than what 
live skin cells in consumers would be expected to be exposed to from using a 
sunscreen.  Therefore, we can conclude that exposure to these Zn and TiO2 
particulates in a sunscreen formulation is unlikely to have detrimental effects on the 
skin. Furthermore, this complements the human field exposure study by Gulson et al. 
[107], who showed that only very small amounts of Zn from ZnO sunscreens are 
absorbed through the skin and detected in the blood at miniscule levels compared to 
healthy Zn concentrations. Therefore, we can further conclude from our dose-
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response profiles that the negligible amount of Zn being absorbed through the skin 
from sunscreens is also unlikely to have detrimental effects. Whilst these results 
would need to be confirmed in primary keratinocytes, we can assume thus far, that 
sunscreens containing NPs are safe to use. However, whilst consumers reserve the 
right to purchase NP-free containing sunscreens irrespective of the results shown in 
this study or elsewhere that indicates their safe use, it is important that they still use 
some form of sunscreen to protect themselves from the risk of excessive exposure to 
a known carcinogen, being the UV component of sunlight.  
Finally, the other groups of people most likely at risk of NP exposure are the 
manufacturers and handlers of nanomaterials. Whilst these individuals might be 
exposed to levels that are close to the lower end of the dose range of what has been 
tested in our system, this would be minimised through safe handling practices and 
appropriate workplace exposure control procedures.  
Whilst this study solely looked at the dermal route of particulate exposure, it is 
important to note that two other forms of potential exposure still exist: inhalation and 
ingestion. Therefore, further studies looking into the effects of particulates in test 
systems relevant to these exposure routes would need to be investigated to determine 
the full extent of the nanosafety profile for these nanomaterials. 
 
5.2 Future Directions 
In the growing field of NT, there will always be the need for further and more 
comprehensive testing. As such, there is a vast array of information that still needs to 
be understood in deciphering the possible mechanisms involved in particulate-
induced toxicity to skin cells.  
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In our study, we observed that the cytotoxicity of ZnO exposure over a 24 h period 
commenced after ~8-12 h of exposure. Therefore, investigating the early events that 
lead up to this timepoint would prove useful, such as measuring the extent of 
activation of apoptosis and necrosis cell death pathways. It would also have been 
useful to run a time-course to observe how the cell death pathways activated may 
change over a 24 h period, which unfortunately was not permitted by time constraints 
in the project. Furthermore, as the mechanisms of cell death involved can be a 
complex process, it may not be sufficient to use only one assay in determining cell 
death pathways. Therefore, multiple assays such as: Annexin V/FITC staining, 
cytochrome c release, and caspase 3, 6 and 7 staining, could all be used to further 
investigate whether apoptosis or necrosis is the primary mode of cell death.  
Measuring endpoints such as NP uptake after 1-2 h of exposure, may also shed light 
on this and other aspects of the cellular responses. This could be measured by 
inductively-coupled plasma mass spectrometry to accurately determine how much Zn 
of a known concentration that was given to the cells, actually gets taken up by the 
cells  [112]. Alternatively, one could also use flow cytometry to examine the change 
in “side scatter” intensity over time as a rough indicator of particle uptake, although 
it is highly dependent on agglomeration size of the particles [215, 224]. Furthermore, 
by correlating cell uptake of NPs with the increase in intracellular Zn2+ and resultant 
cytotoxicity observed in this study, it would be possible to substantiate the postulated 
paradigm of Zn-NP induced cytotoxicity, which states that the ZnO particulates are 
taken up into endosomes and elicit their toxic effects via this pathway. If this is the 
case, then using phosphoinositide 3-kinase inhibitors (that also inhibit endocytosis), 
such as wortmannin [225], and nocodazole or cytochalasin D (cytoskeletal inhibitors 
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of actin important for endocytosis), may ameliorate the ZnO-induced cytotoxicity 
[226]. 
The possible role of ROS in causing cytotoxicity in our system still requires further 
investigation. Whilst we found a link between superoxide production and a decrease 
in cell viability, it would be useful to use anti-oxidants such as Vitamin C and E to 
ascertain the proportionate contribution of ROS to the cytotoxicity seen in our study, 
as has recently been shown in THP-1 immune cells [112]. The reason for using these 
two antioxidants are that Vitamin C is water soluble and quenches free radicals in the 
aqueous phase, whilst Vitamin E is lipophilic and quenches lipid radicals in 
membranes of cells and organelles.  
Furthermore, as we showed that cytotoxicity is occurring early on within NP-
exposed HaCaT cells, it may also be useful to measure the ROS signal over a 24 h 
time course of particulate exposure, using flow cytometry. By determining when 
after NP exposure the ROS is generated, and by correlating this with particle uptake 
and Zn2+ release via flow cytometry analysis, it may help formulate a better 
understanding of the pathways involved in ZnO NP-induced cytotoxicity in HaCaT 
cells. 
As HaCaT cells are an immortalised cell line, all the assays described in this thesis as 
well as the assays proposed in this chapter, would need to be investigated and the 
results confirmed using primary skin cells, such as keratinocytes and fibroblasts. As 
primary keratinocytes are a closer representation of normal human skin cells, they 
would provide a more realistic response of human keratinocytes to the effects of NP 
exposure. Furthermore, primary keratinocytes contain a functional p53 gene and thus 
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would be able to arrest the cell cyle at G1 and G2 checkpoints and allow the cell to 
repair damaged DNA from UV exposures and possibly the NP exposures.  
As in vitro studies are “simplistic”, in that they solely look at the effect of NP 
exposure on single to a few cultured cell types, it is important to take this one step 
further and look at more complex ex vivo scenarios. Most published in vivo skin 
exposure studies look separately at the effects of UV radiation and sunscreen 
exposures. It is therefore imperative that the types of studies which should be 
conducted involve the effects of sunscreens and UV radiation collectively on human 
skin explants. This will gain a better understanding of the effects that the particles in 
sunscreens may have in the presence of UV radiation under normal physiological 
conditions.                                                                  
Organotypic skin models (complex co-cultures) are a conventional alternative to skin 
explants. They are a 3-dimensional model comprised of both a dermal layer and fully 
differentiated epidermis. This enables the determination of the effects that UV 
radiation and sunscreens may have in an engineered human skin model. As skin 
explants can be difficult to obtain due to ethical reasons, these “engineered” human 
skin models could be used as a potential alternative [227, 228]. 
Additionally, these types of studies would also serve as time and cost-effective 
alternatives to the use of animal models (such as mouse studies) which, whilst 
routinely used, are known to possess different skin architecture to humans [229]. 
However, other animal models that could be used include porcine skin. Pig skin, has 
been demonstrated to possess many similarities to human skin in relation to 
morphology, cellular composition and immunoreactivity [230]. As such, if animal 
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models were to be used as a human alternative, porcine skin, would serve as the best 
possible animal model.  
Finally, the skin is a complex organ consisting of many layers of cells that all interact 
to produce a response. This kind of scenario is impossible to completely replicate in 
in vitro systems using single cell exposures. With the difficulty of obtaining a 
reliable source of human skin explants, it still may be possible to use more complex 
in vitro co-culture test systems (including immune cells) to further examine the 
response of human skin exposure to particulates and/or UV radiation. These 
aforementioned more-complex types of investigations are necessary before the 
potential hazards of using NPs in sunscreens can be unequivocally ruled out.  
As with many aspects of nanotoxicology research, the possible effect of particulate 
exposure in humans is still poorly understood. One of the main uses of ZnO and TiO2 
particulates is in sunscreens for their UV-protective effects. Therefore, more in depth 
and complex research is still needed to completely ascertain the effects that 
sunscreens have on human skin, with the future research described above possibly 
aiding in removing some of this ambiguity. Although there is still a great deal of 
research required in this field, this should not prevent the public from using 
sunscreen products (nano-based or nano-free) as part of their standard practices to 
help protect their skin from the harmful effects of excessive UV radiation. 
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Estimation of systemic exposure dose 
Using information from the study of Gulson et al. [107], the amount of sunscreen 
applied to the skin of subjects with highest uptake (i.e. females receiving nano ZnO) 
was an average of 3.8 mg/cm2 over a 35 x 26 cm skin section. This equated to a total 
dose of: 910 cm2 x 3.8 mg/cm2 = 3.5 g of sunscreen applied 
As the sunscreen content of ZnO was 20% wt, this equated to a total amount of 
applied ZnO of:   3.5 g x 0.2 = 0.7 g of ZnO 
 
Consider that the total blood Zn tracer amount found in this group was 15.8 µg 
(range 8.6 – 30.8). Then taking the upper limit of 31 µg with total blood volume (4.7 
L) to provide the Zn tracer blood concentration of:  
31 µg / 4.7 L = 6.6 µg/L = 6.6 ng/mL 
 
As Zn is 80% of the weight of ZnO, this equates to a ZnO blood concentration of:  
6.6 ng/mL / 0.8 = 8.25 ng/mL 
 
If taking the worst case scenario that live cells (including keratinocytes) are exposed 
to the systemic blood concentration of 8.25 ng/mL, the in vitro dose range used in 
this study of 1 – 100 µg/mL of ZnO NPs is 120 to 12,000 fold higher. 
 
